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ABSTRACT: A new general three-stage strategy to access polycyclic ring systems bearing all-carbon quaternary centers with high 
enantioselectivity is reported. The required starting materials were readily accessed in racemic form through the -alkynylation of 
ketoesters with EBX (Ethynyl BenziodoXolone) hypervalent iodine reagents. A Pd-catalyzed asymmetric decarboxylation allyla-
tion was then achieved in high yields and enantioselectivities with Trost’s biphosphine ligands. Finally, transition-metal catalyzed 
cyclization of the obtained chiral enynes gave access to fused and spiro polycyclic ring systems constituting the core of many bio-
active natural products. 
The fascinating structure of natural products is the result of 
millions of years of evolution in interaction with biological 
targets. Particularly striking is the high occurrence of complex 
polycyclic ring systems with numerous stereocenters. An in-
teresting substructure present in natural products is constituted 
by a benzene ring fused to at least two further saturated carbo-
cycles. Both fused and spiro ring systems can be found in im-
portant bioactive compounds such as steroids like estradiol or 
alkaloids like buprenorphine.
1
 The presence of all-carbon qua-
ternary centers embedded in the polycyclic core of many of 
these molecules represents a formidable challenge for synthet-
ic chemistry.
2
 In this context, we envisioned that ketone 1 
bearing a 1,5 enyne substructure around an all-carbon quater-
nary center would be an ideal precursor for both fused and 
spiro ring systems (Scheme 1). Addition of an allyl Grignard 
reagent, followed by olefin ring-closing metathesis (RCM) 
would give an easy access to fused ring systems. The 1,5-
enyne itself can be used to access spiro or rearranged ring-
systems based on transition-metal catalysis.
3
 Whereas RCM is 
now a mature method, cyclisomerization reactions to access 
spiro ring systems have been much less investigated. Indeed, 
there are only two examples of such transformations so far, 
both occurring on unsubstituted alkane rings.
3h,3k 
Nevertheless, the main challenge with the proposed strategy 
resided in the enantioselective synthesis of enyne 1. Most syn-
thetic methods known to access 1,5 enynes take advantage of 
the reactivity of a propargylic cation generated through either 
catalytic or stoichiometric Lewis acid activation, allowing 
access only to racemic material.
4 
 Morken and co-workers 
showed recently that a Pd-catalyzed enantiospecific cross-
coupling reaction gave 1,5-enynes with high enantiomeric 
excess starting from enantioenriched activated propargylic 
alcohols and allyl boronic esters.
5a 
 In this report only one ex-
ample leading to all-carbon quaternary centers in a non-cyclic 
product was presented.
 
In 2013, the same group reported a 
kinetic resolution of racemic propargylic esters using chiral 
ligands.
5b 
 
Scheme 1: Our Synthetic Strategy to Access Polycyclic 
Ring Systems.  
 
Clearly, none of the reported methods to access 1,5-enynes 
appeared promising in the context of our synthetic goal, and 
we decided to developed a new strategy based on the enanti-
oselective decarboxylative allylation of ketoesters (Tsuji-Trost 
reaction).
6
 This very successful approach to access all-carbon 
quaternary centers on carbocycles was first introduced by Se-
gusa
7
 and Tsuji
8 
and then further developed into enantioselec-
tive methods by Stoltz
9 
and Trost.
10,11
 Nevertheless, alkynyl 
substituents in α position of the ketoesters have never been 
reported. In this class of substrates, the α-alkynyl group would 
be in conjugation with the formed enolate I and will change its 
electronic properties. It also leads to a major challenge in regi-
oselectivity, as both attack at the  (pathway a) or  position 
 (pathway b) would be possible.
12
 Moreover, α-alkynyl ketoes-
ters are difficult to access because both enolates and acetylides 
are nucleophiles, and connecting them requires therefore an 
Umpolung of the reactivity. To solve the latter synthetic hur-
dle, our group has used hypervalent iodine reagents for the α-
functionalization of carbonyl compounds.
13 
We have in partic-
ular developed an efficient -ethynylation of ketoesters under 
mild conditions using EBX (EthynylBenziodoXolone) rea-
gents.
13a.b
  
Herein, we would like to present the successful implementa-
tion of the outlined three-stage strategy, including: (1) an im-
proved method for the alkynylation of ketoesters at room tem-
perature in up to quantitative yield, (2) the first example of 
enantioselective decarboxylative allylation at propargylic posi-
tion proceeding in up to quantitative yield and with an enanti-
omeric excess higher than 90% on 5, 6 and 7-membered rings 
and (3) the use of the obtained enynes to access fused and 
spiro tricyclic ring systems via a RCM or cycloisomerization 
strategy, as well as the unanticipated formation of a rearranged 
[6,6,5,3] ring system. 
Preliminary studies showed that the decarboxylation-
allylation sequence proceeded only in very low yield with 
ketoesters bearing a free acetylene obtained using our previ-
ously published alkynylation method.
13a 
We consequently first 
investigated the possibility to access protected acetylenes in 
the -alkynylation of -keto esters with hypervalent iodine 
reagents. Using diazabicycloundecene (DBU) or tetramethyl-
guanidine (TMG) as a base, the desired alkynes 2 could be 
obtained in up to quantitative yield at room temperature using 
TIPS-EBX (4a) and TPDPS-EBX (4b) starting from the corre-
sponding ketoesters 3 (eq. 1).
14
 
 
Preliminary studies on the decarboxylative allylation were 
then conducted using substrate 2a under the reaction condi-
tions previously reported by Stoltz.
9d
 The substrate was con-
verted fully to the desired allylation product 1a, but no enanti-
omeric excess was obtained using the PHOX ligand 5a (Table 
1, entry 1). A switch in the Pd source to Pd(cinnamyl)Cp (6), 
an established clean precursor of Pd(0) phosphine complex-
es,
15 
did not improve the result (entry 2). Keeping 
Pd(cinnamyl)Cp (6) as the Pd source, we turned then our at-
tention to Trost ligand 5b which had been applied previously 
in the decarboxylation of allyl ketoesters.
10b
 Also in this case 
full conversion to 1a was observed, but with no enantioselec-
tivity (entry 3). However, changing the solvent to Et2O gave 
for the first time a measurable enantioselectivity of 12% (entry 
4). A screening of other Trost ligands in Et2O led to better 
results with an encouraging 59% ee for 5c, 76% ee for 5d and 
74% ee for 5e (entries 5-7). Changing the solvent to MTBE 
gave the desired product in 70% ee with 5d and 79% ee with 
5e (entries 8 and 9). Final optimization of the reaction condi-
tions led to the best results at room temperature with 5 mol % 
palladium loading and a concentration of 0.1 M in MTBE 
(entry 10).
16
 In the case of ketoester 2b bearing a sterically 
more hindered methallyl substituent the enantioselectivity 
reached a remarkably high 93% ee even with only 2 mol % 
palladium (entry 11).
17 
This result is impressive as only mod-
erate enantioselectivity has been reported in the past when 
using indanone substrates and acyclic allyl groups: 76-84% ee 
with Trost ligands
10
 and 71-80% ee with phenyloxazoline 
(PHOX) ligands.
9d 
Several indanone derivatives were then subjected to the op-
timized reaction conditions on a 0.12 mmol scale. 1,5-Enyne 
1a was obtained in 89% ee using indanone 2a (Scheme 2). 
Compound 2b yielded product 1b in 93% ee and quantitative 
yield. A different silyl group (TBDPS) on the acetylene could 
also be used to give enyne 1c. Without silyl protecting group, 
the desired product 1d was obtained in 41% yield and 87% 
ee.
18
 A high tolerance towards the electronic properties and the 
position of the substituents on the aromatic ring was observed. 
Neutral indanone 1e was obtained in quantitative yield and 
94% ee. Bromo and chloro substituents were also well tolerat-
ed (products 1f and 1g), but a lower enantiomeric excess was 
observed in the case of trifluoromethylated product 1h. 
Table 1. Optimization of the Pd-Catalyzed Decarboxyla-
tive Allylation. 
 
entry reaction conditionsa L eeb 
1 [Pd2(dba)3], THF 5a 0 
2 Pd(cinnamyl)Cp (6), THF  5a 0 
3 6, THF 5b 0 
4 6, Et2O 5b 12 
5 6, Et2O 5c 59 
6 6, Et2O 5d 76 
7 6, Et2O 5e 74 
8 6, MTBE 5d 70 
9 6, MTBE 5e 79 
10 5 mol % 6/ 5 mol % L, MTBE, 0.1 M 5e 86 
11 2 mol % 6/ 2.5 mol % L, MTBE, 0.1 Mc 5e 93 
aAll the reaction mixtures were degased three times and stirred 
at room temperature for 8-12 h using substrate 2a (0.01 mmol), 
the indicated solvent (0.033 M), Pd source (20 mol %) and ligand 
(44 mol %) unless stated otherwise. All the reactions gave full 
conversion to the desired product 1a exclusively (yield > 90% by 
1H NMR). bThe ee was determined by HPLC using Chiralcel col-
umns. cSubstrate 2b was used. 
 
 Scheme 2: Scope of the Pd-catalyzed Decarboxylative Allylation.  
 
Isolated yields after column chromatography using the conditions of entry 11 in table 1 on 0.12 mmol scale are reported. aUsing 
Pd(cinnamyl)Cp (6) (5 mol %) and ligand 5e (6.5 mol %). bThe (S,S)-enantiomer of ligand 5e was used. 
 
Modification of the substituent on the allyl group was also 
possible: both chloroallyl enyne 1i and enyne 1j bearing a 
protected alcohol were obtained in high enantiomeric excess 
and yield. When changing to tetralones, ee higher than 96% 
were observed (products 1k-l).
 
A lower enantioselectivity was 
obtained for enyne 1m with a simple allyl substituent. Fused 
heterocycle 1n and cycloheptanone 1o could also be accessed 
in good yields and 90% ee.  
In order to access fused ring systems, allyl Grignard was 
then added to ketone 1b and the corresponding alcohol 7b was 
obtained in quantitative yield and with 4.5:1 diastereoselectivi-
ty (Scheme 3). Fused [6,5,6] tricyclic compound 8b was then 
synthesized in 83% yield from the syn isomer of 7b via ring-
closing metathesis using Grubbs II ruthenium catalyst. Using 
the same synthetic sequence, [6,6,6] tricyclic compound 8k 
was obtained in 65% overall yield.
19
 
Scheme 3: Synthesis of Fused Ring Systems 
 
To study new cycloisomerization reactions, free acetylene 
1d and 10 were synthesized in gram scale (9.9 and 3.4 mmol) 
in a one-pot asymmetric allylation-silyl deprotection sequence 
from ketoester 2b and 2k in 83% yield/95% ee and 64% 
yield/97% ee respectively (Scheme 4). When the synthesis of 
spiro compound 11a was attempted using PtCl2 as catalyst 
with enyne 1d as reported by Kozmin and co-workers,
3i
 cyclo-
propane product 9 was obtained instead in 52% yield (Scheme 
4, A).
20
 The formation of 9 can be explained by the intermedi-
acy of a platinum-carbenoid, followed by 1,2- shift and re-
aromatization. The first two steps of this sequence have been 
reported by Toste and co-workers, but using a gold catalyst.
3h
  
Scheme 4: Au- and Pt-Catalyzed Cycloisomerizations. 
 
Fortunately and somewhat surprisingly, we found that gold 
catalysis, which usually favours formation of the cyclopropane 
products, could be used in this case to access the spiro carbo-
cyclic compounds. Diene 11a and its non-conjugated isomer 
12a were obtained in 88% yield using PPh3AuClO4 as catalyst 
(Scheme 4, B) In the case of tetralone 10, cyclization was 
much slower and could not be achieved using PPh3AuClO4 as 
catalyst. Higher activity was displayed by PPh3AuPF6, which 
gave the desired spiro tricyclic ring system in 64% yield.  
In conclusion, we have reported a new three-stage strategy 
to access polycyclic ring systems efficiently and in high enan-
tio purity. The first step of our approach was the synthesis of 
α-alkynylated -ketoesters in high yields using EBX hyperva-
lent iodine reagents to achieve the Umpolung of acetylide. 
Cornerstone of the strategy was the second step: the first effi-
cient enantioselective synthesis of 1,5-enynes bearing an all-
carbon propargylic quaternary center achieved through a Pd-
catalyzed decarboxylative allylation starting from racemic 
ketoesters. The Pd-catalyzed decarboxylation allylation gave 
high enantioselectivity by using the DACH-naphthyl Trost 
 ligand, which had never been used for the allylation of propar-
gylic positions before. In the third stage, the chiral 1,5-enynes 
obtained were finally converted into the desired tricyclic 
[6,5,6] and [6,6,6] fused and spiro ring systems using ring-
closing metathesis and cycloisomerization reactions respec-
tively. Furthermore, the unanticipated synthesis of a new 
[6,6,5,3] ring system could also be achieved with a platinum 
catalyst. The stage is now ready for using the strategy in the 
synthesis of natural and synthetic bioactive compounds and for 
extending it to other types of carbocyclic or heterocyclic scaf-
folds. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). All chemicals were 
purchased from Acros, Aldrich, Fluka, VWR, Fluorochem, Aplichem or Merck and used without 
further purification, unless stated otherwise. Chromatographic purification was performed as 
flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as 
eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC aluminium 
plates and visualized with UV light and anisaldehyde stain. Melting points were measured on a 
calibrated Büchi B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra 
were recorded on a Bruker DPX-400 400 MHz spectrometer in chloroform-d and/or DMSO-d6. 
All signals are reported in ppm with the internal chloroform signal at 7.26 ppm or the internal 
DMSO signal at 2.50 ppm as standard. The data is being reported as (s = singlet, d = doublet, t = 
triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, app = 
apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were recorded 
with 1H-decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d and/or 
DMSO-d6. All signals are reported in ppm with the internal chloroform signal at 77.0 ppm or the 
internal DMSO signal at 39.5 ppm as standard. Infrared spectra were recorded on a JASCO FT-
IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-
1 (w = weak, m = medium, s = strong, br = broad). Gas chromatographic and low resolution 
mass spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas 
chromatographer and mass spectrometer using a Perkin-Elmer Elite fused silica column (length: 
30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass spectrometric 
measurements were performed by the mass spectrometry service of ISIC at the EPFL on a 
MICROMASS (ESI) Q-TOF Ultima API. All the chiral ligands used in this work are 
commercially available. 
  
S4 
 
2. Synthesis of Hypervalent iodine Reagents 
2.1 Synthesis of 1-Hydroxy-1,2-benziodoxol-3(1H)-one (14) 
 
Following a reported procedure,[1] NaIO4 (6.7 g, 31 mmol, 1.0 equiv) and 2-iodobenzoic acid 
(13) (7.4 g, 30 mmol, 1.0 equiv) were suspended in 30% (v:v) aq. AcOH (45 mL). The mixture 
was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with cold 
water (120 mL) and allowed to cool to room temperature, protecting it from light. After 1 h, the 
crude product was collected by filtration, washed on the filter with ice water (3 x 30 mL) and 
acetone (3 x 30 mL), and air-dried in the dark to give the pure product 14 (7.3 g, 19 mmol, 92%) 
as a colorless solid.  
1H NMR (400 MHz, (CD3)2SO) δ 8.02 (dd, J = 7.7, 1.4, Hz, 1H, ArH), 7.97 (m, 1H, ArH), 
7.85 (dd, J = 8.2, 0.7  Hz, 1H; ArH), 7.71 (td, J = 7.6, 1.2, Hz, 1H, ArH).  
13C NMR (100 MHz, (CD3)2SO) δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4.  
IR νmax 3083 (w), 3060 (w), 2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 
1338 (s), 1302 (m), 1148 (m), 1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m).  
The characterization data for compounds 14 corresponded to the reported values.1 
2.2 Synthesis of 1-[(Triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (4a) 
Triiso-propylsilyl trimethylsilylacetylene (16) 
 
Following a reported procedure,2 n-butyllithium (2.5 M in hexanes, 12.0 mL, 29.9 mmol, 0.98 
equiv) was added dropwise to a stirred solution of ethynyltrimethylsilane (15) (3.0 g, 30 mmol, 
1.0 equiv) in THF (48 mL) at –78 °C. The mixture was then warmed to 0 °C and stirred for 5 
min. The mixture was then cooled back to –78 °C and chlorotriiso-propylsilane (6.4 mL, 30 
mmol, 1.0 equiv) was added dropwise. The mixture was then allowed to warm to room 
temperature and stirred overnight. A saturated solution of ammonium chloride (40 mL) was 
added, and the reaction mixture was extracted with diethyl ether (2 x 60 mL). The organic layer 
was washed with water and brine, then dried over MgSO4, filtered and concentrated under 
                                                 
(1)  L. Kraszkiewicz, L. Skulski, Arkivoc, 2003, 6, 120. 
(2) C J. Helal, P. A. Magriotis, E. J. Corey, J. Am. Chem. Soc. 1996, 118, 10938. 
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reduced pressure to obtain a colorless liquid which was further purified by Kugelrohr distillation 
(56-57°C/0.25 mmHg) to yield 16 (7.16 g, 28.0 mmol, 92% yield) as a colorless liquid.  
1H NMR (400 MHz, CDCl3) δ 1.08 (m, 21H, TIPS), 0.18 (s, 9H, TMS).  
IR νmax 2959 (m), 2944 (m), 2896 (w), 2867 (m), 1464 (w), 1385 (w), 1250 (m), 996 (w), 842 
(s), 764 (s), 675 (m), 660 (m).  
Characterization data of 16 corresponded to the literature values.2 
1-[(Triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (4a) 
 
Following a reported procedure,3 trimethylsilyltriflate (3.6 mL, 20 mmol, 1.1 equiv, freshly 
distilled) was added dropwise to a stirred solution of 2-iodosylbenzoic acid (14) (4.7 g, 18 mmol, 
1.0 equiv) in acetonitrile (140 mL). (Trimethylsilyl)(triiso-propylsilyl)acetylene (16) (5.0 g, 20 
mmol, 1.1 equiv) was then added dropwise, followed, after 15 min, by the addition of pyridine 
(1.5 mL, 20 mmol, 1.1 equiv). The mixture was stirred 10 min. The solvent was then removed 
under reduced pressure and the yellow crude oil was dissolved in dichloromethane (50 mL). The 
organic layer was washed with 1 M HCl (50 mL) and the aqueous layer was extracted with 
CH2Cl2 (50 mL). The organic layers were combined, washed with a saturated solution of 
NaHCO3 (2 x 50 mL), dried over MgSO4, filtered and the solvent was evaporated under reduced 
pressure. Recrystallization from acetonitrile (ca 35 mL) afforded 4a (6.3 g, 15 mmol, 83%) as a 
colorless solid.  
Mp (Dec.) 170-176°C. 
1H NMR (400 MHz, CDCl3) δ 8.44 (m, 1H, ArH), 8.29 (m, 1H, ArH), 7.77 (m, 2H, ArH), 
1.16 (m, 21H, TIPS).  
13C NMR (100 MHz, CDCl3) δ 166.4, 134.6, 132.3, 131.4, 131.4, 126.1, 115.6, 114.1, 64.6, 
18.4, 11.1.  
IR νmax 2943 (m), 2865 (m), 1716 (m), 1618 (m), 1604 (s), 1584 (m), 1557 (m), 1465 (m), 
1439 (w), 1349 (m), 1291 (m), 1270 (w), 1244 (m), 1140 (m), 1016 (m), 999 (m), 883 (m), 833 
(m), 742 (m), 702 (s), 636 (m).  
Characterization data of 4a corresponded to the literature values.3 
 
                                                 
3 V. V.Zhdankin , C. J Kuehl, A. P Krasutsky, J. T. Bolz, A. J. Simonsen, J. Org. Chem. 1996, 61, 6547. 
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2.3 Synthesis of 1-[(tertButyldiphenylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (9b) 
tertButyldiphenylsilyl trimethylsilylacetylene (17) 
 
Following a reported procedure,4 n-butyllithium (2.5 M in hexanes, 8.0 mL, 20 mmol, 0.98 
equiv) was added dropwise to a stirred solution of ethynyltrimethylsilane (15) (2.90 mL, 20.4 
mmol, 1.0 equiv) in THF (30 mL) at –78 °C. The mixture was then warmed to 0 °C and stirred 
for 5 min. The mixture was then cooled back to –78 °C and tert-butylchlorodiphenylsilane (6.4 
mL, 30 mmol, 1.0 equiv) was added dropwise. The mixture was then allowed to warm to room 
temperature and stirred overnight. A saturated solution of ammonium chloride (30 mL) was 
added, and the reaction mixture was extracted with diethyl ether (2 x 50 mL). The organic layer 
was washed with water and brine, then dried over MgSO4, filtered and concentrated under 
reduced pressure to obtain a colorless liquid which was further purified by Kugelrohr distillation 
(bp = 150°C, p = 0.25 mmHg) to yield 17 (2.95 g, 8.76 mmol, 44% yield) as a colorless liquid.  
1H NMR (400 MHz, CDCl3) δ 7.80 (m, 4H, ArH), 7.38 (m, 6H, ArH), 1.08 (s, 9H, tBu), 0.27 (s, 
9H, TMS). 
13C NMR (101 MHz, CDCl3) δ 135.6, 133.2, 129.5, 127.7, 119.0, 108.7, 27.0, 18.5, -0.0.  
The characterization data for compound 17 corresponded to the reported values.4 
1-[(tertButyldiphenylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (4b) 
 
Following a reported procedure,5 Trimethylsilyltriflate (1.58 mL, 8.70 mmol, 1.1 equiv, freshly 
distilled) was added dropwise to a stirred solution of 2-iodosylbenzoic acid (14) (2.07 g, 7.90 
mmol, 1.0 equiv) in acetonitrile (30 mL). Butyldiphenyl((trimethylsilyl)ethynyl)silane (17) (2.95 
g, 3.70 mmol, 1.1 equiv) was then added dropwise, followed, after 15 min, by the addition of 
pyridine (710 μL, 3.70 mmol, 1.1 equiv). The mixture was stirred 10 min. The solvent was then 
removed under reduced pressure and the yellow crude oil was dissolved in dichloromethane. The 
organic layer was washed with 1 M HCl and the aqueous layer was extracted with CH2Cl2. The 
organic layers were combined, washed with a saturated solution of NaHCO3, dried over MgSO4, 
filtered and the solvent was evaporated under reduced pressure. The resulting oil was stirred in 
hexane and ether and then reduced under vacuum to afford a colorless solid. Recrystallization 
from acetonitrile (ca 20 mL) afforded 4b (2.77 g, 5.42 mmol, 69%) as a colorless solid. 
1H NMR (400 MHz, CDCl3) (ca 0.12 mmol/mL) δ 8.43 (d, J = 6.5 Hz, 1H, ArH), 8.29 (d, J = 
8.2 Hz, 1H, ArH), 7.82 (d, J = 6.6 Hz, 4H, ArH), 7.75 (t, J = 7.2 Hz, 1H, ArH), 7.66 (m, 1H, 
ArH), 7.53-7.41 (m, 6H, ArH), 1.21 (s, 9H, tBu). 
                                                 
(4) P. Cuadrado, A.M. Gonzalez-Nogal, R. Valero, Tetrahedron 2002, 58, 4975. 
(5) J. P Brand, C. Chevalley, R. Scopelliti, J. Waser, Chem. Eur. J. 2012, 18, 5655. 
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13C NMR (101 MHz, CDCl3) δ 166.6, 135.5, 134.8, 132.4, 131.5, 131.3, 130.2, 128.1, 126.3, 
116.0, 112.2, 68.5, 27.0, 18.7. One carbon was not resolved.  
IR νmax 3072 (w), 2958 (w), 2932 (w), 2865 (w), 2860 (w), 2248 (w), 1649 (w), 1622 (m), 1561 
(w), 1471 (w), 1430 (w), 1336 (w), 1297 (w), 1253 (w), 1113 (w), 1008 (w), 906 (s), 821 (w), 
727 (s), 647 (m).  
The characterization data for compounds 4b corresponded to the reported values.5 
2.4 Synthesis of 1-[(Trimethylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (4c) 
1-[(Trimethylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (4c) 
 
Following a reported procedure,3 trimethylsiyltriflate (2.8 mL, 15 mmol, 1.4 equiv, freshly 
distilled) was added dropwise to a stirred solution of 2-iodosylbenzoic acid (14) (3.00 g, 11.4 
mmol, 1.00 equiv) in acetonitrile (85 mL) until the mixture turned colorless. 
Bis(trimethylsilyl)acetylene (2.14 g, 12.5 mmol, 1.10 equiv) was then added dropwise, followed, 
after 20 min, by the addition of pyridine (1.2 mL, 15 mmol, 1.4 equiv). The mixture was stirred 
30 min. The solvent was then removed under reduced pressure and the yellow crude oil was 
dissolved in dichloromethane (80 mL). The organic layer was washed with a large amount of 
water (130 mL), and the aqueous layer was extracted with CH2Cl2 (3 x 65 mL). The organic layer 
was washed with brine (130 mL), dried over MgSO4, filtered and the solvent was evaporated 
under reduced pressure. Recrystallization from acetonitrile (2.3 mL) afforded 4c (2.35 g, 6.84 
mmol, 60% yield) as a colorless solid.  
Mp: 143-145°C (dec);  
1H NMR (400 MHz, CDCl3) δ 8.42 (dd, J = 6.4, 1.9 Hz, 1H, ArH), 8.19 (m, 1H,ArH), 7.78 (m, 
2H, ArH), 0.32 (s, 9H, TMS) 
13C NMR (100 MHz, CDCl3) 166.4, 134.9, 132.6, 131.7, 131.4, 126.1, 117.2, 115.4, 64.2, -0.5.  
IR νmax 3389 (w), 2967 (w), 1617 (s), 1609 (s), 1562 (m), 1440 (w), 1350 (m), 1304 (w), 1254 
(w), 1246 (w), 1112 (w), 1008 (w), 852 (s), 746 (m), 698 (m), 639 (m).  
The characterization data for compounds 4c corresponded to the reported values.3 
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3. Synthesis of starting materials: allyl β-keto esters.  
General procedure for the synthesis of β-allyl keto esters. 
 
Following a reported procedure,6 potassium tert-butoxide (0.05 equiv) was added to a suspension 
of NaH (2.2 equiv) in diallyl carbonate (2.0 equiv). The ketone (1 equiv) was then added 
dropwise at 0 °C. The reaction was stirred at room temperature and followed by TLC (using the 
solvent mixture indicated below for the Rf value and UV or p-anisaldehyde for visualization). 
Then 1 M HCl was added until the pH of the solution became neutral or slightly acidic. The 
organic layers were collected and washed with brine (2 x 20 mL), dried over MgSO4 and 
concentrated in vacuum. The crude product was purified by column chromatography, using the 
solvent indicated for the Rf value. 
Allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3a) 
Starting from 5-methoxy-2,3-dihydro-1H-inden-1-one (0.200 g, 1.23 mmol), allyl 5-methoxy-1-
oxo-2,3-dihydro-1H-indene-2-carboxylate 3a (0.209 g, 0.851 mmol, 69 % yield) was obtained as 
a brown solid.  
RF 0.3 (pentane:ethyl acetate 3:2).  
Mp: 53.5-55.9° C. 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.2 Hz, 1H, ArH), 6.96 – 6.89 (m, 2H, ArH), 
5.94 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H, CHCH2), 5.37 (dq, J = 17.2, 1.5 Hz, 1H, CHCH2), 5.25 (dq, 
J = 10.5, 1.3 Hz, 1H, CHCH2), 4.69 (tt, J = 5.7, 1.4 Hz, 2H, CH2CH), 3.90 (s, 3H, OMe), 3.74 
(dd, J = 8.2, 4.0 Hz, 1H, CH), 3.52 (dd, J = 17.3, 4.0 Hz, 1H, CH2), 3.32 (dd, J = 17.3, 8.2 Hz, 
1H, CH2). 
13C NMR (101.00 MHz, Chloroform-d) δ 197.4, 169.1, 165.9, 156.7, 131.7, 128.5, 126.4, 
118.6, 116.0, 109.6, 66.2, 55.8, 53.5, 30.3. 
IR νmax 3021 (w), 3013 (w), 2842 (w), 1738 (m), 1705 (s), 1598 (s), 1491 (w), 1337 (w), 1307 
(m), 1259 (s), 1224 (w), 1193 (m), 1156 (m), 1149 (m), 1105 (m), 1089 (m), 1025 (m), 989 (m). 
HRMS (ESI) calcd for C14H15O4+ [M+H]+ 247.0965; found 247.0960. 
2-Methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3b) 
                                                 
(6) M.V. Vita, J. Waser, Org. Lett. 2013, 15, 3246. 
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Starting from 5-methoxy-2,3-dihydro-1H-inden-1-one (1.76 g, 10.9 mmol), 2-methylallyl 5-
methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate 3b (2.17 g, 8.34 mmol, 77 % yield) was 
obtained as a yellowish oil.  
RF 0.6 (pentane:ethyl acetate 7:3).  
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.1 Hz, 1H, ArH), 6.96-6.92 (m, 2H, ArH), 
5.03 (dd, J = 1.6, 0.9 Hz, 1H, CMeCH2), 4.94 (m, 1H, CMeCH2), 4.68 – 4.54 (m, 2H, CH2CMe), 
3.90 (s, 3H, OCH3), 3.78 (dd, 1 H, J = 8.2, 4.0 Hz, CH), 3.55 (dd, 1 H, J = 17.3, 4.0 Hz, CH2), 
3.35 (dd, 1 H, J = 17.3, 8.2 Hz), 1.78 (dd, J = 1.6, 0.9 Hz, 3H, CCH3). 
13C NMR (101 MHz, Chloroform-d) δ 197.3, 169.1, 165.9, 156.7, 139.6, 128.6, 126.4, 116.0, 
113.3, 109.6, 68.7, 55.8, 53.5, 30.3, 19.5. 
IR νmax 2978 (w), 2969 (w), 2942 (w), 1740 (m), 1706 (s), 1600 (s), 1306 (w), 1261 (s), 1156 
(m), 1090 (m). 
HRMS (ESI) calcd for C15H16NaO4+ [M+Na]+ 283.0941; found 283.0944. 
2-Methylallyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3e) 
Starting from 2,3-dihydro-1H-inden-1-one (0.500 g, 3.78 mmol), 2-methylallyl 1-oxo-2,3-
dihydro-1H-indene-2-carboxylate 3e (0.653 g, 2.84 mmol, 75% yield) was obtained as a purple 
liquid.  
RF 0.3 (pentane:ethyl acetate 3:2).  
1H NMR (400 MHz, Chloroform-d) (ketone/enol 1:0.2) Ketone: δ 7.78 (d, J = 7.7 Hz, 1H, 
ArH), 7.63 (dd, J = 8.1, 6.8 Hz, 1H, ArH), 7.51 (d, J = 7.7 Hz, 1H, ArH), 7.43 – 7.36 (m, 1H, 
ArH), 5.05 – 4.91 (m, 2H, CMeCH2), 4.72 – 4.52 (m, 2H, CH2CMe), 3.77 (dd, J = 8.3, 4.1 Hz, 
1H, CHCH2), 3.64 – 3.52 (m, 1H, CH2CH), 3.40 (dd, J = 17.2, 8.2 Hz, 1H, CH2CH), 1.78 (d, J = 
1.4 Hz, 3H, CMe). Enol: δ 7.65 (m, 1H, ArH), 7.47 (d, J = 1.3 Hz, 1H, ArH), 7.44 (dd, J = 7.3, 
1.4 Hz, 1H, ArH), 7.39 (m, 1H, ArH), 5.05 (d, J = 1.5 Hz, 1H, CMeCH2), 4.98 (t, J = 1.4 Hz, 1H, 
CMeCH2), 4.69 (s, 2H, CH2CMe), 3.56 (s, 2H, CH2 ), 1.82 (s, 3H, CMe). 
13C NMR (101.00 MHz, Chloroform-d) Ketone: δ 199.3, 168.8, 153.5, 139.5, 135.4, 135.3, 
127.9, 126.6, 124.7, 113.4, 68.8, 53.3, 30.3, 19.5. Enol: δ 143.2, 140.0, 136.9, 129.5, 126.9, 
124.8, 120.8, 112.8, 102.2, 67.1, 32.5, 29.7. (2C in the enol are missing, one possibly the ester). 
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IR νmax 1746 (s), 1716 (s), 1464 (w), 1328 (w), 1314 (w), 1300 (w), 1286 (w), 1274 (w), 1248 
(w), 1207 (m), 1186 (m), 1155 (m), 1128 (w), 991 (w), 990 (w), 917 (w), 908 (w), 765 (m). 
HRMS (ESI) calcd for C14H15O3+ [M+H]+ 231.1016; found 231.1017. 
2-Methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3f) 
Starting from 5-bromo-2,3-dihydro-1H-inden-1-one (0.500 g, 2.37 mmol), 2-methylallyl 5-
bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate 3f (0.501 g, 1.62 mmol, 68% yield) was 
obtained as a yellow solid. 
RF 0.3 (pentane:ethyl acetate 3:2).  
Mp: 58.2-61.9 °C. 
1H NMR (400 MHz, Chloroform-d) Keto/enol form (1.5:1) keto: δ 7.69 (d, J = 1.6 Hz, 1H, 
ArH), 7.63 (d, J = 8.2 Hz, 1H, ArH), 7.56 – 7.51 (m, 1H, ArH), 5.02 (s, 1H, CCH2), 4.95 (s, 1H, 
CCH2), 4.68 – 4.54 (m, 2H, CH2C), 3.77 (dd, J = 8.3, 4.1 Hz, 1H, CH), 3.54 (dd, J = 17.4, 4.0 
Hz, 1H, CH2), 3.37 (dd, J = 17.5, 8.3 Hz, 1H, CH2), 1.79 – 1.76 (m, 3H, CCH3). Enol: δ 10.31 (s, 
1H, OH), 7.62 (s, 1H, ArH), 7.52 – 7.50 (m, 2H, ArH), 5.05 – 5.03 (m, 1H, CCH2), 4.98 (t, J = 
1.4 Hz, 1H, CCH2), 4.69 (s, 2H, CH2C), 3.53 (s, 2H, CH2), 1.82 (t, J = 1.1 Hz, 3H, CCH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 198.0, 168.3, 155.1, 144.9, 139.9, 139.4, 135.9, 
134.1, 131.6, 131.0, 130.2, 129.9, 128.1, 125.8, 124.0, 122.0, 113.5, 113.0, 102.5, 68.9, 67.3, 
53.3, 32.4, 30.0, 19.5, 19.5. (2 aromatic C of the enol form are not resolved). 
IR νmax 2977 (w), 2940 (w), 2934 (w), 1742 (m), 1717 (s), 1652 (m), 1620 (m), 1597 (m), 1562 
(m), 1418 (m), 1316 (m), 1288 (m), 1260 (m), 1211 (s), 1200 (s), 1179 (s), 1159 (m), 1133 (m), 
1101 (m), 992 (m), 911 (m). 
HRMS (ESI) calcd for C14H1379BrNaO3+ [M+Na]+ 330.9940; found 330.9943. 
2-Methylallyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3g) 
Starting from 6-chloro-2,3-dihydro-1H-inden-1-one (0.50 g, 3.0 mmol), 2-methylallyl 6-chloro-1-
oxo-2,3-dihydro-1H-indene-2-carboxylate 3g (0.59 g, 2.2 mmol, 74 % yield)was obtained as pink 
solid.  
RF 0.3 (pentane:ethyl acetate 3:2).  
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Mp: 71.5-73.7° C. 
1H NMR (400 MHz, Chloroform-d) Keto/enol ratio (1:0.5) Ketone δ 7.73 (d, J = 2.1 Hz, 1H, 
ArH), 7.58 (dd, J = 8.2, 2.1 Hz, 1H, ArH), 7.39 (d, J = 1.3 Hz, 1H, ArH), 5.04 – 5.00 (s, 1H, 
CCH2), 4.97 – 4.93 (s, 1H, CCH2), 4.68 – 4.52 (m, 2H, CH2C), 3.80 (dd, J = 8.2, 4.0 Hz, 1H, 
CH), 3.54 (dd, J = 17.3, 4.0, 1H, CH2), 3.36 (dd, J = 17.4, 8.1 Hz, 1H, CH2), 1.77 (s, 3H, CCH3). 
Enol: δ 10.25 (s, 1H, OH), 7.62 (s, 1H, ArH), 7.45 (d, J = 8.1 Hz, 2H, ArH), 5.05 (s, 1H, CCH2), 
4.98 (s, 1H, CCH2), 4.69 (s, 2H, CH2C), 3.54 (s, 2H, CH2), 1.82 (d, J = 1.5 Hz, 3H, CCH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 198.0, 168.3, 151.6, 141.2, 139.9, 139.4, 138.6, 
136.8, 135.5, 134.3, 133.1, 129.4, 127.7, 125.8, 124.4, 120.9, 113.5, 113.0, 103.7, 69.0, 67.3, 
53.7, 32.3, 29.9, 19.5, 19.4. (2 aromatic C of the enol form are not resolved). 
IR νmax 2975 (w), 2935 (w), 2861 (w), 2860 (w), 1745 (m), 1720 (s), 1652 (m), 1620 (m), 1592 
(m), 1568 (m), 1339 (m), 1255 (s), 1201 (s), 1187 (s), 1166 (m), 1131 (m), 1107 (m), 907 (w), 
777 (w). 
HRMS (ESI) calcd for C14H13ClNaO3+ [M+Na]+ 287.0445; found 287.0441. 
2-Methylallyl 6-trifluoromethyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3h) 
Starting from 6-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one (0.23 ml, 1.5 mmol), 2-methylallyl 
1-oxo-6-(trifluoromethyl)-2,3-dihydro-1H-indene-2-carboxylate 3h (0.32 g, 1.1 mmol, 71 % 
yield) was obtained as pink solid.  
RF 0.25 (pentane:ethyl acetate 9:1).  
Mp: 56.7-59.2° C. 
1H NMR (400 MHz, Chloroform-d) (Ketone/enol 0.5:1) Ketone δ 8.05 (d, J = 1.7 Hz, 1H, 
ArH), 7.66 (d, J = 8.2 Hz, 2H, ArH), 5.05 – 5.02 (m, 1H, CCH2), 4.96 (t, J = 1.5 Hz, 1H, CCH2), 
4.65 (s, 1H, CH2CMe), 4.58 (d, J = 13.0 Hz, 1H, CH2CMe), 3.85 (dd, J = 8.3, 4.0 Hz, 1H, CH2), 
3.71 – 3.64 (m, 1H, CH2), 3.46 (dd, J = 17.7, 7.9 Hz, 1H, CH2), 1.81 – 1.76 (m, 3H, CH2CMe). 
Enol: δ 10.29 (s, 1H, OH), 7.93 – 7.90 (m, 1H, ArH), 7.88 (dd, J = 8.2, 1.7 Hz, 1H, ArH), 7.59 
(d, J = 7.9 Hz, 1H, ArH), 5.06 (p, J = 1.2 Hz, 1H, CMeCH2), 5.00 (q, J = 1.3 Hz, 1H, CMeCH2), 
4.71 (s, 2H, CH2CMe), 3.63 (s, 2H, CH2), 1.86 – 1.80 (m, 3H, CCH3). 
13C NMR (101 MHz, Chloroform-d) δ 198.0, 168.6, 168.5, 168.1, 156.6, 146.5, 139.8, 139.3, 
137.6, 135.7, 131.9 (q, J = 3.6 Hz), 130.7 (t, J = 33.1 Hz), 129.7 (d, J = 32.4 Hz), 127.4, 126.10 
(q, J = 3.8 Hz), 125.1, 124.2 (q, J = 272.2 Hz), 123.6 (q, J = 273 Hz), 122.0 (q, J = 4.0 Hz), 117.9 
(q, J = 3.9 Hz), 113.6, 113.1, 103.7, 69.1, 67.4, 53.5, 32.8, 30.4, 19.5, 19.4. 
19F NMR (376 MHz, CDCl3) δ -62.1, -62.6.  
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IR νmax 2944 (w), 1724 (m), 1657 (m), 1324 (s), 1269 (s), 1254 (m), 1215 (m), 1189 (m), 1164 
(s), 1128 (s), 1103 (s), 909 (m). 
HRMS (ESI) calcd for C15H13F3NaO3+ [M+Na]+ 321.0709; found 321.0695. 
2-Methylallyl 6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3k) 
Starting from 6-methoxy-3,4-dihydronaphthalen-1(2H)-one (1.50 g, 8.51 mmol), 2-methylallyl 6-
methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate 3k (1.55 g, 5.65 mmol, 66 % yield) 
was obtained as yellow oil.  
RF 0.85 (dichloromethane/pentane 5:1).  
1H NMR (400 MHz, Chloroform-d) (keto/enol 1:0.3) Ketone δ 8.03 (d, J = 8.8 Hz, 1H, ArH), 
6.84 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 6.70 – 6.68 (m, 1H, ArH), 4.99 (s, 1H, CMeCH2), 4.92 (s, 
1H, CMeCH2), 4.68 (d, J = 12.2 Hz, 1H, CH2CMe), 4.60 (d, J = 13.2 Hz, 1H, CH2CMe), 3.86 (s, 
3H, OMe), 3.61 (dd, J = 10.1, 4.7 Hz, 1H, CHCH2), 3.09 – 2.90 (m, 2H, CHCH2), 2.56 – 2.44 (m, 
1H, CH2CH2), 2.40 – 2.30 (m, 1H, CH2CH2), 1.75 (dd, J = 1.5, 0.8 Hz, 3H, CMe). Enol: δ 12.4 
(s, 1H, OH), 7.74 (d, J = 8.5 Hz, 1H, ArH), 6.80 (dd, J = 8.6, 2.6 Hz, 1H, ArH), 6.71 (d, J = 2.6 
Hz, 1H, ArH), 5.02 (s, 1H, CMeCH2), 4.96 (s, 1H, CMeCH2), 4.63 (s, 2H, CH2CMe) 3.84 (s, 3H, 
OMe), 2.80 (dd, J = 8.9, 6.6 Hz, 2H, CH2CH2), 2.64 – 2.57 (m, 2H, CH2CH2), 1.80 (dd, J = 1.5, 
0.8 Hz, 3H, CMe). 
13C NMR (101.00 MHz, Chloroform-d) Ketone: δ 191.7, 170.1, 163.9, 146.1, 139.7, 130.3, 
125.4, 113.5, 113.2, 112.6, 68.3, 55.5, 54.4, 28.1, 26.5, 19.5. Enol: δ 172.4, 165.8, 161.6, 141.8, 
140.1, 126.2, 122.8, 113.2, 112.6, 111.7, 94.8, 67.4, 55.4, 28.3, 20.6, 19.5. 
IR νmax 2942 (w), 2841 (w), 1739 (m), 1677 (m), 1601 (s), 1277 (s), 1250 (s), 1210 (s), 1151 (m). 
HRMS (ESI) calcd for C16H19O4+ [M+H]+ 275.1278; found 275.1269. 
2-Methylallyl-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3l) 
Starting from 3,4-dihydronaphthalen-1(2H)-one (0.50 g, 3.4 mmol), 2-methylallyl 1-oxo-1,2,3,4-
tetrahydronaphatane-2-carboxylate 3l (0.80 g, 3.4 mmol, 99% yield) was obtained as yellow 
liquid. 
RF 0.4 (pentane:dichloromethane 1:1).  
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1H NMR (400 MHz, Chloroform-d) (ketone/enol 1:1) Ketone δ 7.84 (dd, J = 7.5, 1.6 Hz, 1H, 
ArH), 7.35 (dtd, J = 8.5, 4.3, 1.4 Hz, 2H, ArH), 7.32 – 7.27 (m, 1H, ArH), 5.02 (s, 1H, CMeCH2), 
4.95 (t, J = 1.4 Hz, 1H, CMeCH2), 4.68 (s, 2H, CH2CMe), 3.69 (dd, J = 10.3, 4.7 Hz, 1H, CH), 
3.16 – 2.99 (m, 2H, CH2), 2.62 – 2.50 (m, 1H, CH2), 2.42 (ddt, J = 13.5, 5.9, 4.7 Hz, 1H, CH2), 
1.79 – 1.76 (m, 3H, CH2CMe). Enol: δ 12.42 (s, 1H, OH), 8.08 (dd, J = 8.0, 1.4 Hz, 1H, ArH), 
7.53 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.33 – 7.27 (m, 1H, ArH), 7.23 – 7.19 (m, 1H, ArH), 5.06 (s, 
1H, CMeCH2), 5.00 (s, 1H, CMeCH2), 4.71 – 4.57 (m, 2H, CH2CMe), 2.86 (dd, J = 8.9, 6.6 Hz, 
2H, CH2), 2.69 – 2.61 (m, 2H, CH2), 1.88 – 1.81 (m, 3H, CH2CMe). 
13C NMR (101.00 MHz, Chloroform-d) ( Ketone/enol 1:1) δ 193.1, 172.3, 169.9, 165.4, 143.6, 
139.9, 139.6, 139.4, 133.9, 131.8, 130.6, 130.0, 128.8, 127.8, 127.4, 126.9, 126.6, 124.4, 113.4, 
112.8, 96.9, 68.4, 67.6, 54.6, 27.8, 27.7, 26.5, 20.5, 19.5, 19.4. 
IR νmax 3077 (w), 2975 (w), 2943 (w), 2844 (w), 1742 (m), 1687 (m), 1647 (s), 1619 (m), 1599 
(m), 1454 (m), 1386 (m), 1357 (m), 1325 (m), 1307 (m), 1297 (m), 1269 (s), 1212 (s), 1200 (m), 
1170 (m), 1156 (m), 1136 (m), 1087 (m), 907 (m), 768 (m), 744 (m). 
HRMS (ESI) calcd for C15H17O3+ [M+H]+ 245.1172; found 245.1166. 
Allyl-6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3m) 
Starting from 6-methoxy-3,4-dihydronaphthalen-1(2H)-one(0.50 g, 2.8 mmol), allyl 6-methoxy-
1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate 3m (0.50 g, 2.0 mmol, 70% yield) was 
obtained as a brown oil.  
RF 0.3 (pentane:ethylacetate 8:2).  
1H NMR (400 MHz, Chloroform-d) (ketone/enol 1:0.3) Ketone: δ 8.02 (d, J = 8.8 Hz, 1H, 
ArH), 6.84 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 6.70 – 6.67 (m, 1H, ArH), 5.99 – 5.89 (m, 1H, 
CHCH2), 5.32 (q, J = 1.5 Hz, 1H, CHCH2), 5.24 (dq, J = 10.5, 1.3 Hz, 1H, CHCH2), 4.74 – 4.63 
(m, 2H, CH2CH), 3.86 (s, 3H, OMe), 3.60 (dd, J = 10.3, 4.7 Hz, 1H, CH), 3.10 – 2.87 (m, 2H, 
CH2), 2.49 (dddd, J = 13.4, 10.3, 9.4, 4.9 Hz, 1H, CH2), 2.35 (ddt, J = 13.4, 5.9, 4.7 Hz, 1H, 
CH2). Enol: δ 7.74 (d, J = 8.6 Hz, 1H, ArH), 6.80 (dd, J = 8.6, 2.6 Hz, 1H, ArH), 6.70 (d, J = 2.5 
Hz, 1H, ArH), 6.05 – 5.94 (m, 1H, CHCH2), 5.40 – 5.33 (m, 1H, CHCH2), 5.25 (m, 1H, CHCH2), 
4.73 – 4.69 (m, 2H, CH2CH), 3.83 (s, 3H, OMe), 2.79 (dd, J = 8.9, 6.6 Hz, 2H, CH2), 2.63 – 2.56 
(m, 2H, CH2). 
13C NMR (101.00 MHz, Chloroform-d) Ketone:δ 191.7, 170.1, 164.0, 146.1, 131.9, 130.3, 
125.3, 118.4, 113.49, 112.6, 65.8, 55.5, 54.4, 28.1, 26.5. Enol: δ 172.4, 165.8, 161.6, 141.8, 
132.4, 126.2, 122.8, 118.0, 113.2, 111.7, 94.8, 64.9, 55.4, 28.3, 20.6. 
IR νmax 2942 (w), 2907 (w), 2842 (w), 1738 (m), 1676 (m), 1600 (s), 1306 (m), 1273 (s), 1250 
(s), 1210 (s), 1167 (m), 1152 (m), 1092 (m), 914 (m), 733 (s). 
HRMS (ESI) calcd for C15H17O4+ [M+H]+ 261.1121; found 261.1128. 
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2-Methylallyl 4-oxo-4,5,6,7-tetrahydrobenzofuran-5-carboxylate (3n) 
Starting from 6,7-dihydrobenzofuran-4(5H)-one (0.50 g, 3.7 mmol) 2-methylallyl 4-oxo-4,5,6,7-
tetrahydrobenzofuran-5-carboxylate 3n (0.64 g, 2.7 mmol, 75 % yield) was obtained as a green 
liquid.  
RF 0.33 (pentane/ethy acetate 7:3). 
1H NMR (400 MHz, Chloroform-d) δ 7.33 (d, J = 2.0 Hz, 1H, ArH), 6.69 (dd, J = 2.1, 0.9 Hz, 
1H, ArH), 5.00 – 4.88 (m, 2H, CMeCH2), 4.66 – 4.51 (m, 2H, CH2CMe), 3.54 (dd, J = 8.5, 4.7 
Hz, 1H, CH), 3.06 (dt, J = 17.6, 6.0 Hz, 1H, CH2), 2.90 (ddd, J = 17.6, 7.5, 5.5 Hz, 1H, CH2), 
2.58 (ddddd, J = 13.9, 8.4, 7.4, 5.4, 0.8 Hz, 1H, CH2), 2.44 – 2.33 (m, 1H, CH2), 1.74 (d, J = 1.3 
Hz, 3H, CH2CMe).  
13C NMR (101 MHz, Chloroform-d) δ 188.6, 169.5, 166.5, 143.1, 139.5, 120.5, 113.3, 106.8, 
68.5, 53.3, 25.9, 21.9, 19.4. 
IR νmax 2945 (w), 1739 (s), 1682 (s), 1622 (w), 1598 (w), 1518 (w), 1455 (m), 1446 (m), 1363 
(w), 1346 (w), 1305 (m), 1270 (w), 1240 (w), 1201 (m), 1173 (w), 1156 (m), 1123 (m), 1027 (w), 
982 (w), 942 (w), 910 (w), 875 (w), 738 (w), 717 (w). 
HRMS (ESI) calcd for C13H15O4+ [M+H]+ 235.0965; found 235.0963. 
2-Methylallyl 5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulene-6-carboxylate (3o) 
Starting from 5-methoxy-2,3-dihydro-1H-inden-1-one (1.00 g, 6.17 mmol), 2-methylallyl 5-
methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate 3o (0.952 g, 3.66 mmol, 59 % yield) was 
obtained as colorless liquid.  
RF 0.4 (dichloromethane/pentane 1:1).  
1H NMR (400 MHz, Chloroform-d) (ketone/enol 0.3:1) Ketone:δ 7.67 (dd, J = 7.7, 1.5 Hz, 1H, 
ArH), 7.35 (dd, J = 7.5, 1.5 Hz, 1H, ArH), 7.25 – 7.21 (m, 1H, ArH), 7.13 (m, 1H, ArH), 4.91 (t, 
J = 1.3 Hz, 1H, CMeCH2), 4.87 – 4.84 (m, 1H, CMeCH2), 4.56 – 4.46 (m, 2H, CH2CMe), 3.78 
(dd, J = 10.4, 4.4 Hz, 1H, CH), 2.89 (t, J = 5.1 Hz, 2H, CH2), 2.08 (m, 2H, CH2), 2.00 (m, 1H, 
CH2), 1.84 – 1.75 (m, 1H, CH2), 1.67 (t, J = 1.1 Hz, 3H, CH2CMe). Enol: δ 12.51 (s, 1H, OH), 
7.55 (dd, J = 7.1, 2.0 Hz, 1H, ArH), 7.29 – 7.24 (m, 2H, ArH), 7.18 – 7.13 (m, 1H, ArH), 4.98 – 
4.94 (m, 1H, CMeCH2), 4.89 (t, J = 1.4 Hz, 1H, CMeCH2), 4.59 (s, 2H, CH2CMe), 2.57 (t, J = 
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6.9 Hz, 2H, CH2), 2.10 (td, J = 6.6, 1.6 Hz, 2H, CH2), 2.07 – 1.99 (m, 2H, CH2), 1.76 – 1.72 (m, 
3H, CMeCH2). 
13C NMR (101.00 MHz, Chloroform-d) (ketone/enol 0.3:1) Ketone: δ 200.5, 172.6, 170.1, 
141.2, 139.7, 138.1, 132.4, 129.9, 129.2, 126.8, 68.5, 56.7, 32.8, 25.4, 24.4, 19.5 . Enol:  δ 170.7, 
141.1, 140.0, 135.7, 130.2, 129.0, 127.2, 126.4, 113.4, 112.7, 100.2, 67.6, 33.6, 31.8, 21.9, 19.5 
IR νmax 3080 (w), 2976 (w), 2938 (w), 2887 (w), 2882 (w), 2860 (w), 1747 (s), 1681 (w), 1640 
(m), 1618 (w), 1592 (w), 1567 (w), 1450 (m), 1383 (w), 1362 (w), 1343 (w), 1298 (m), 1270 (s), 
1241 (s), 1202 (m), 1190 (m), 1158 (w), 1127 (m), 1095 (w), 989 (m), 945 (w), 908 (m), 821 (w), 
790 (w), 772 (m). 
HRMS (ESI) calcd for C16H19O3+ [M+H]+ 259.1329; found 259.1329. 
3.1 Synthesis of substrates 3i and 3j. 
MeO
O
O
OEt
HO
R
DMAP, 5 A MS
toluene
MeO
O
O
O
R
MeO
O
EtO OEt
O
THF
18 19  
Ethyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (19) 
Following a reported procedure,7 potassium tert-butoxyde (6.9 mg, 0.062 mmol, 0.0050 equiv.) 
was added to a suspension of NaH (1.1 g, 27 mmol, 2.2 equiv.) and diethyl carbonate (7.5 mL, 62 
mmol, 5.0 equiv.). 5-Methoxy-2,3-dihydro-1H-inden-1-one (18) (2.0 g, 12 mmol) was then added 
carefully at 0 °C. The reaction was stirred at room temperature and followed by TLC. Then 1 M 
HCl was added until the pH of the solution became neutral or slightly acidic. The organic layers 
were collected and washed with brine (2 x 20 mL), dried over MgSO4 and concentrated in 
vacuum. The crude product was purified by column chromatography (7:3 Pentane/Ethyl acetate) 
and the pure compound (19) was obtained in 96% yield (2.8 g, 12 mmol, 96%). 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.1 Hz, 1H, ArH), 6.94 – 6.89 (m, 2H, ArH), 
4.29 (dd, 1H, J = 7.2, 0.9 Hz, CH2CH3), 4.25 (dd, 1H, J = 7.2, 0.8 Hz, CH2CH3), 3.89 (s, 3H, 
OMe), 3.70 (dd, J = 8.2, 3.9 Hz, 1H, CH), 3.50 (ddt, J = 17.2, 4.0, 1.0 Hz, 1H, CH2), 3.33 (dd, 1 
H, J = 17.3, 8.1 Hz, CH2), 1.31 (t, J = 7.1 Hz, 3H, CH2CH3).  
The characterization data for compounds 19 corresponded to the reported values.8 
2-Chloroallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3i) 
                                                 
(7) M.V. Vita, J. Waser, Org. Lett. 2013, 15, 3246-3249. 
(8) A. Martinez, M. Fernandez, J. Estevez, J.R. Estevez, L. Castaldo, Tetrahedron 2005, 61, 1353-1362 
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Substrate 3i was synthetized following a reported procedure,[9] in a 2-neck 50 mL flask 
compound 19 (0.71 g, 3.0 mmol), DMAP (0.37 g, 3.0 mmol, 1.0 equiv.), 2-chloroprop-2-en-1-ol 
(0.29 g, 3.2 mmol, 1.05 equiv.) and c.a 200-300 mg of activated 5Å MS were heated to reflux till 
disappearance of the starting material (TLC 9:1, pentane/ethyl acetate). The reaction was 
quenched with HCl 1 M and water; the aqueous layer was extracted with diethyl ether (2x 30 
mL). The organic layers were collected, washed with NaHCO3, brine, dried over MgSO4., filtered 
and concentrated under reduced pressure. The crude is purified by column chromatography: 1:1 
pentane/DCM, 4:1 DCM/penatane and then 100% DCM. The title compound 3i (0.49 g, 1.8 
mmol, 58 % yield) is obtained as yellow oil. 
1H NMR (400 MHz, Chloroform-d) δ 7.69 (d, J = 9.2 Hz, 1H, ArH), 6.99 – 6.83 (m, 2H, ArH), 
5.58 (q, J = 1.5 Hz, 1H, CClCH2), 5.40 (dt, J = 1.9, 0.8 Hz, 1H, CClCH2), 4.86 – 4.63 (m, 2H, 
CH2CCl), 3.89 (s, 3H, OMe), 3.77 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.52 (dd, J = 17.4, 4.0 Hz, 1H, 
CH2), 3.33 (dd, J = 17.3, 8.2 Hz, 1H, CH2). 
13C NMR (101 MHz, CDCl3) δ 197.0, 168.5, 166.0, 156.6, 135.1, 128.3, 126.4, 116.1, 114.8, 
109.6, 66.4, 55.8, 53.3, 30.2. 
IR νmax 2944 (w), 2843 (w), 1746 (m), 1705 (s), 1599 (s), 1491 (w), 1337 (w), 1306 (m), 1259 
(s), 1190 (w), 1144 (m), 1105 (m), 1089 (m), 1026 (w), 987 (w). 
HRMS (ESI) calcd for C14ClH14O4+ [M+H]+ 281.0575; found 281.0568. 
2-(((tert-Butyldiphenylsilyl)oxy)methyl)prop-2-en-1-ol (21) 
 
Following a reported procedure,10 2-methylenepropane-1,3-diol (20) (0.50 mL, 6.1 mmol) was 
dissolved in THF (15 mL), the solution was cooled at 0 °C before the addition of NaH (0.25 g 
60% dispersed in mineral oil, 6.1 mmol, 1.0 equiv.). After 1 h, TBDPSCl (1.6 mL, 6.1 mmol, 1.0 
equiv.) was added and the reaction was stirred at room temperature for 18-20 h. The solution was 
then cooled to 0 °C and quenched with iced water and then extracted with diethyl ether (3 x 50 
mL). The organic layers are recombined and washed with a saturated solution of K2CO3 (50 mL), 
brine (50 mL) and dried over Na2SO4. Evaporation of the solvent afforded compound 21 (2.0 g, 
6.1 mmol, 99% yield) as a colorless oil which was used without further purification for the 
transesterification. 
1H NMR (400 MHz, Chloroform-d) δ 7.82 – 7.62 (m, 4H, Ph), 7.52 – 7.30 (m, 6H, Ph), 5.16 (s, 
1H, CCH2), 5.12 (s, 1H, CCH2), 4.26 (s, 2H, CH2C), 4.20 – 4.16 (m, 2H, CH2C), 1.08 (s, 9H, 
tBu). 
The characterization data for compounds 21 corresponded to the reported values.10 
                                                 
(9) J. Hierold, D.W. Lupton, Org. Lett. 2012, 14, 3412-3415. 
(10) F. Russo, F. Wangsell, J. Saevmarker, M. Jacobsson, M. Larhed, Tetrahedron 2009, 65, 10047-10059. 
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2-(((tert-Butyldiphenylsilyl)oxy)methyl)allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (3j) 
Substrate 8j was synthetized following a reported procedure,11 in a 2 neck 50 mL flask compound 
19 (0.30 g, 1.3 mmol) DMAP (0.16 g, 1.3 mmol, 1.0 equiv.), 2-((tert-
butyldiphenylsilyl)methyl)prop-2-en-1-ol (21) (0.44 g, 1.4 mmol, 1.1 equiv.) and c.a 200-300 mg 
of activated 5Å MS were heated to reflux till disappearance of the starting material (TLC 8:2, 
pentane/ethyl acetate). The reaction was quenched with 1M HCl and water; the aqueous layer 
was extracted with diethyl ether (2 x 30 mL). The organic layers were collected and washed with 
NaHCO3 and brine and then dried over MgSO4. Filtration and removal of the solvent under 
reduced pressure afforded the crude product which was purified by column chromatography (8:2 
penatane/ethylacetate). The title compound 3j (0.28 g, 0.53 mmol, 42 % yield) was obtained as a 
colorless oil  
1H NMR (400 MHz, Chloroform-d) δ 7.71 – 7.64 (m, 4H, Ph+ ArH), 7.46 – 7.33 (m, 7H, Ph), 
6.91 (ddd, J = 8.6, 1.9, 1.1 Hz, 1H, ArH), 6.90 – 6.88 (m, 1H, ArH), 5.30 (s, 1H, CMeCH2), 5.22 
(s, 1H, CMeCH2), 4.77 – 4.67 (m, 2H, CH2CMe), 4.21 (dt, J = 2.2, 1.4 Hz, 2H, CH2OTBDPS), 
3.89 (s, 3H, OMe), 3.68 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.44 (dd, J = 17.3, 4.1 Hz, 1H, CH2), 3.33 
– 3.21 (m, 1H, CH2), 1.05 (s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 197.2, 169.0, 165.9, 156.6, 142.3, 135.5, 133.4, 129.7, 
128.5, 127.7, 126.4, 115.9, 113.1, 109.6, 65.6, 64.5, 55.8, 53.4, 30.3, 26.8, 19.3. 
IR νmax 2956 (w), 2932 (w), 2858 (w), 1744 (w), 1743 (w), 1709 (s), 1600 (s), 1261 (s), 1111 (s), 
1090 (m). 
HRMS (ESI) calcd for C31H35O5Si+ [M+H]+ 515.2248; found 515.2248.
                                                 
(11) J. Hierold, D.W. Lupton , Org. Lett. 2012, 14, 3412-3415. 
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4. General procedure for the synthesis of α-alkynyl allyl β-keto esters. 
In a 2-neck flask DBU or TMG (1.2 equiv.) was added to a solution of the allyl β-keto ester 3 in 
toluene (0.08 M). The reaction was stirred for a few minutes followed by the addition in one 
portion of the hypervalent iodine reagent 4 (1.5 equiv.). The reaction was stirred at room 
temperature till disappearance of the starting material by TLC. Upon completion the reaction was 
quenched with water (20 mL) and extracted with diethyl ether (3 x 20 mL). The organic layers 
were recombined, washed with NaHCO3 (20 mL), brine (20 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The corresponding crude was purified by flash 
chromatography as indicated by the RF values for each compound. 
 
Figure S1. Scope of the α-alkynylation of β-allyl keto esters with hypervalent iodine EBX 
reagents. 
Allyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-carboxylate 
(2a) 
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Starting from 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3a) (0.300 g, 1.22 mmol), 
allyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-carboxylate (2a) 
(0.518 g, 1.35 mmol, 99 % yield) was obtained as a yellow oil using DBU as the base in the 
general procedure.  
RF 0.3 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 8.5 Hz, 1H, ArH), 6.99 – 6.86 (m, 2H, ArH), 
5.89 (ddt, J = 16.3, 10.7, 5.5 Hz, 1H, CHCH2), 5.34 (dt, J = 17.2, 1.7 Hz, 1H, CHCH2), 5.21 (dd, 
J = 10.5, 1.5 Hz, 1H, CHCH2), 4.66 (m, 2H, CH2CH), 3.90 (s, 3H, OMe), 3.89 (d, J = 16.9 Hz, 
1H, CH2), 3.43 (d, J = 17.1 Hz, 1H, CH2), 1.05 (d, J = 1.7 Hz, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 193.9, 168.1, 166.1, 155.2, 131.3, 127.5, 126.4, 118.5, 
116.3, 109.4, 103.4, 85.2, 66.8, 56.7, 55.8, 41.2, 18.6, 11.2. 
IR νmax 2944 (m), 2893 (w), 2866 (m), 2171 (w), 1720 (s), 1599 (s), 1464 (w), 1262 (s), 1210 
(m), 1182 (w), 1105 (w), 1092 (m), 884 (m). 
HRMS (ESI) calcd for C25H34NaO4Si+ [M+Na]+ 449.2119; found 449.2110. 
2-Methylallyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-
carboxylate (2b) 
Starting from 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3b) (1.00 g, 
3.84 mmol, 2-methylallyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
indene-2-carboxylate (2b) (1.68 g, 3.84 mmol, 99 % yield) was obtained as a yellow solid using 
DBU as a base in the general procedure. 
RF 0.35 (pentane:ethyl acetate 8:2).  
Mp: 37.9-42.7°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 8.5 Hz, 1H, ArH), 6.94 (dd, J = 8.6, 2.1 Hz, 
1H, ArH), 6.91 – 6.89 (m, 1H, ArH), 5.00 (s, 1H, CCH2), 4.90 (s, 1H, CCH2), 4.60 (d, J = 13.1 
Hz, 1H, CH2CMe), 4.56 (d, J = 13.1 Hz, 1H, CH2CMe), 3.90 (m, 1H, CH2), 3.90 (s, 3H, OMe), 
3.44 (dd, J = 16.9, 1.0 Hz, 1H, CH2), 1.74 (dd, J = 1.5, 0.9 Hz, 3H, CH3), 1.05 (d, J = 1.6 Hz, 
21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 193.9, 168.1, 166.1, 155.2, 139.2, 127.4, 126.5, 116.2, 
113.3, 109.4, 103.4, 85.1, 69.5, 56.8, 55.8, 41.2, 19.3, 18.6, 11.2. 
IR νmax 2944 (m), 2866 (m), 2172 (w), 1722 (s), 1623 (s), 1602 (s), 1264 (s). 
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HRMS (ESI) calcd for C26H37O4Si+ [M+H]+ 441.2456; found 441.2454. 
2-Methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-5-methoxy-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (2c) 
Starting from 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3b) (0.0600 
g, 0.231 mmol), 2-methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-5-methoxy-1-oxo-2,3-dihydro-
1H-indene-2-carboxylate (2c) (0.0960 g, 0.184 mmol, 80 % yield with 92% purity) was obtained 
as a brown oil using DBU as a base and TBDPS-EBX (4b) as the reagent in the general 
procedure. 
RF 0.33 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.90 – 7.69 (m, 5H, Ph), 7.43 – 7.29 (m, 6H, Ph + ArH), 
7.03 – 6.88 (m, 2H, ArH), 5.04 (s, 1H, CCH2), 4.92 (s, 1H, CCH2), 4.64 (s, 2H, CH2C), 3.97 (d, J 
= 17.2 Hz, 1H, CH2), 3.91 (s, 3H, OMe), 3.55 (d, J = 17.1 Hz, 1H, CH2), 1.75 (s, 3H, CH3), 1.07 
(s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 193.5, 167.9, 166.3, 155.3, 139.2, 135.6, 133.1, 133.1, 
129.5, 127.7, 126.3, 116.4, 113.6, 109.5, 105.7, 84.4, 72.8, 69.8, 57.0, 55.8, 40.8, 27.0, 19.4. 
IR νmax 4488 (w), 3072 (w), 2953 (w), 2933 (w), 2892 (w), 2858 (w), 2174 (w), 1719 (s), 1599 
(s), 1262 (s), 1108 (m), 740 (m). 
HRMS (ESI) calcd for C33H35O4Si+ [M+H]+ 523.2299; found 523.2305. 
2-Methylallyl 2-ethynyl-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (2d) 
Starting from 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3b) (0.517 
g, 1.99 mmol), 2-methylallyl 2-ethynyl-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate 
(2d) (0.530 g, 1.86 mmol, 94 % yield) was obtained as a yellow oil using TMG as a base and 
TMS-EBX (4c) as the reagent in the general procedure. 
RF 0.31 (pentane:ethyl acetate 7:3). 
1H NMR (400 MHz, Chloroform-d) δ 7.75 (d, J = 8.6 Hz, 1H, ArH), 6.98 – 6.93 (m, 1H, ArH), 
6.93 – 6.89 (m, 1H, ArH), 4.97 (s, 1H, CCH2), 4.91 (s, 1H, CCH2), 4.43 (d, J = 13.2 Hz, 1H, 
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CH2CMe), 4.39 (d, J = 13.2 Hz, 1H, CH2CMe), 3.91 (s, 3H, OMe), 3.87 (m, 1H, CH2), 3.51 – 
3.42 (m, 1H, CH2), 2.42 (s, 1H, CH), 1.72 (dd, J = 1.6, 0.9 Hz, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 193.8, 167.6, 166.4, 155.3 139.1, 127.5, 126.2, 116.5, 
113.3, 109.4, 80.2, 72.2, 69.6, 55.9, 55.8, 40.4, 19.3. 
IR νmax 3291 (w), 3275 (w), 2944 (w), 1750 (m), 1717 (s), 1659 (w), 1600 (s), 1493 (w), 1449 
(w), 1339 (w), 1306 (w), 1264 (s), 1203 (w), 1183 (w), 1150 (w), 1104 (w), 1093 (m), 1057 (w), 
1025 (w), 985 (w), 942 (w), 928 (w), 906 (w), 848 (w), 829 (w), 747 (w), 736 (w), 680 (w), 664 
(w), 647 (w), 635 (s), 621 (w), 607 (w). 
HRMS (ESI) calcd for C17H17O4+ [M+H]+ 285.1121; found 285.1124. 
2-Methylallyl 1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-carboxylate (2e) 
Starting from 2-methylallyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3e) (0.207 g, 0.899 
mmol), 2-methylallyl 1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-carboxylate 
(2e) (0.365 g, 0.889 mmol, 99 % yield) was obtained as a yellow oil using DBU as a base in the 
general procedure. 
RF 0.3 (pentane:ethyl acetate 95:5).  
1H NMR (400 MHz, Chloroform-d) δ 7.82 (dt, J = 7.7, 0.9 Hz, 1H, ArH), 7.65 (td, J = 7.5, 1.2 
Hz, 1H, ArH), 7.49 (dt, J = 7.8, 0.9 Hz, 1H, ArH), 7.42 (ddd, J = 7.9, 7.2, 1.0 Hz, 1H, ArH), 5.01 
– 4.96 (m, 1H, CMeCH2), 4.92 – 4.88 (m, 1H, CMeCH2), 4.59 (d, J = 13.8 Hz, 1H, CH2CMe), 
4.56 (d, J = 13.9 Hz, 1H, CH2CMe), 3.95 (d, J = 17.0 Hz, 1H, CH2), 3.50 (d, J = 17.2 Hz, 1H, 
CH2), 1.73 (t, J = 1.1 Hz, 3H, CMe), 1.04 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 195.9, 167.8, 152.1, 139.1, 135.7, 133.5, 128.1, 126.4, 
125.7, 113.4, 103.0, 85.5, 69.6, 56.5, 41.2, 19.3, 18.6, 11.2. 
IR νmax 2943 (m), 2892 (w), 2865 (m), 2171 (w), 1728 (s), 1464 (m), 1245 (m), 1208 (m), 1189 
(m), 1176 (m), 918 (m), 883 (m), 751 (m), 736 (m). 
HRMS (ESI) calcd for C25H35O3Si+ [M+H]+ 411.2350; found 411.2356. 
2-Methylallyl 5-bromo-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-
carboxylate (3f) 
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Starting from 2-methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3f) (0.20 g, 
0.65 mmol), 2-methylallyl 5-bromo-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-
2-carboxylate (2f) (0.28 g, 0.56 mmol, 87 % yield) was obtained as a yellow solid using DBU as 
a base in the general procedure. 
RF 0.33 (pentane:ethyl acetate 95:5).  
Mp: 42.1-44.4°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.65 – 7.55 (m, 2H, ArH), 7.57 – 7.46 (m, 1H, ArH), 4.92 
(dt, J = 2.6, 1.3 Hz, 1H, CCH2), 4.85 (ddd, J = 2.7, 1.8, 1.1 Hz, 1H, CCH2), 4.59 (d, J = 14.7 Hz, 
1H, CH2CMe), 4.56 (d, J = 13.9 Hz, 1H, CH2CMe), 3.86 (d, J = 17.2 Hz, 1H, CH2), 3.46 – 3.34 
(m, 1H, CH2), 1.73 – 1.61 (m, 3H, CCH3), 0.97 (s, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 194.7, 167.5, 153.6, 139.0, 132.3, 131.9, 131.3, 129.7, 
126.8, 113.6, 102.4, 86.0, 69.7, 56.5, 40.8, 19.3, 18.6, 11.2. 
IR νmax 2943 (m), 2892 (w), 2865 (m), 2172 (w), 1730 (s), 1597 (m), 1582 (w), 1464 (w), 1430 
(w), 1289 (w), 1256 (m), 1205 (m), 1180 (m), 1060 (w), 996 (w), 943 (w), 918 (m), 884 (m), 751 
(w). 
HRMS (ESI) calcd for C25H3379BrNaO3Si+ [M+Na]+ 511.1275; found 511.1273. 
2-Methylallyl 6-chloro-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-
carboxylate (2g) 
Starting from 2-methylallyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3g) (0.300, 
1.13 mmol), 2-methylallyl 6-chloro-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-
2-carboxylate (2g) (0.500 g, 1.12 mmol, 99 % yield) was obtained as a yellow oil using DBU as a 
base in the general procedure. 
RF 0.37 (dichloromethane:pentane 1:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.62 (dd, J = 2.1, 0.7 Hz, 1H, ArH), 7.45 (dd, J = 8.2, 2.1 
Hz, 1H, ArH), 7.28 (dq, J = 8.2, 0.9 Hz, 1H, ArH), 4.83 (dq, J = 2.0, 1.2 Hz, 1H, CMeCH2), 4.76 
(ddt, J = 2.2, 1.5, 0.8 Hz, 1H, CMeCH2), 4.62 (d, J = 13.8 Hz, 1H, CH2CMe), 4.58 (d, J = 13.9 
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Hz, 1H, CH2CMe), 3.75 (dt, J = 17.2, 0.7 Hz, 1H, CH2), 3.37 – 3.24 (m, 1H, CH2), 1.58 (dd, J = 
1.5, 0.9 Hz, 3H, CCH3), 0.89 (s, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 194.7, 167.5, 150.1, 139.0, 135.8, 135.0, 134.5, 127.6, 
125.4, 113.6, 102.3, 86.1, 69.7, 57.0, 40.8, 19.3, 18.6, 11.2. 
IR νmax 2943 (m), 2892 (w), 2866 (m), 2173 (w), 1731 (s), 1465 (m), 1262 (m), 1246 (m), 1197 
(s), 1186 (s), 884 (m). 
HRMS (ESI) calcd for C25ClH34O3Si+ [M+H]+ 445.1960; found 445.1945. 
2-Methylallyl 1-oxo-6-(trifluoromethyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
indene-2-carboxylate (2h) 
Starting from 2-methylallyl 1-oxo-6-(trifluoromethyl)-2,3-dihydro-1H-indene-2-carboxylate (3h) 
(0.15 g, 0.50 mmol), 2-methylallyl 1-oxo-6-(trifluoromethyl)-2-((triisopropylsilyl)ethynyl)-2,3-
dihydro-1H-indene-2-carboxylate (2h) (0.14 g, 0.30 mmol, 60 % yield) was obtained as colorless 
oil.  
RF 0.35 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 8.05 – 8.00 (m, 1H, ArH), 7.89 – 7.79 (m, 1H, ArH), 7.63 
– 7.53 (m, 1H, ArH), 4.93 (p, J = 1.2 Hz, 1H, CMeCH2), 4.85 (ddd, J = 2.6, 1.8, 1.0 Hz, 1H, 
CMeCH2), 4.61 (d, J = 14.1 Hz, 1H, CH2CMe), 4.57 (d, J = 14.1 Hz, 1H, CH2CMe), 3.95 (d, J = 
17.5 Hz, 1H, CH2), 3.48 (d, J = 17.5 Hz, 1H, CH2), 1.73 – 1.62 (m, 3H, CCH3), 0.97 (s, 21H, 
TIPS). 
13C NMR (101 MHz, CDCl3) δ 194.7, 167.3, 155.2, 139.0, 134.0 – 132.0 (m), 131.1 (q, J = 33.1 
Hz), 127.2, 123.5 (q, J = 272 Hz), 122.9 (q, J = 3.8 Hz). 122.9, 113.7, 102.0, 86.4, 69.9, 56.8, 
41.2, 19.3, 18.6, 11.1.  
19F NMR (376 MHz, CDCl3) δ -62.6. 
IR νmax 2943 (m), 2895 (w), 2866 (m), 2173 (w), 1734 (s), 1332 (s), 1250 (s), 1200 (s), 1186 (s), 
1136 (s). 
HRMS (ESI) calcd for C26H33F3NaO3Si+ [M+Na]+ 501.2043; found 501.2031. 
2-Chloroallyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-
carboxylate (2i) 
O O
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Starting from 2-chloroallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3i) (0.467 g, 
1.66 mmol), 2-chloroallyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
indene-2-carboxylate (2i) (0.700 g, 1.52 mmol, 91 % yield) was obtained as a brown oil using 
DBU as a base in the general procedure. 
RF 0.38 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 8.5 Hz, 1H, ArH), 6.98 – 6.93 (m, 1H, ArH), 
6.91 (q, J = 1.1 Hz, 1H, ArH), 5.56 (q, J = 1.6 Hz, 1H, CCH2), 5.38 (dt, J = 1.9, 1.0 Hz, 1H, 
CCH2), 4.71 (q, J = 1.1 Hz, 2H, CH2C), 3.91 (d, J = 17.1, 1.0 Hz, 1H, CH2), 3.91 (s, 3H, OMe), 
3.46 (d, J = 17.1, 1.0 Hz, 1H, CH2), 1.05 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 193.5, 167.6, 166.2, 155.2, 134.6, 127.5, 126.3, 116.4, 
114.5, 109.5, 102.9, 85.6, 66.9, 56.6, 55.8, 41.1, 18.6, 11.2. 
IR νmax 2943 (m), 2893 (w), 2865 (m), 2171 (w), 1721 (s), 1599 (s), 1262 (s), 1203 (m), 1093 
(m), 1070 (m), 884 (m). 
HRMS (ESI) calcd for C25H33ClNaO4Si+ [M+Na]+ 483.1729; found 483.1740. 
 
2-(((Tert-butyldiphenylsilyl)oxy)methyl)allyl 5-methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-
2,3-dihydro-1H-indene-2-carboxylate (2j) 
Starting from 2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (3j) (0.152 g, 0.295 mmol), 2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl 5-
methoxy-1-oxo-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-indene-2-carboxylate (2j) (0.180 g, 
0.259 mmol, 88 % yield) was obtained as a colorless oil. 
RF 0.3 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.6 Hz, 1H, ArH), 7.66 – 7.61 (m, 4H, Ph), 
7.39 (m, 6H, Ph), 6.92 (dd, J = 8.6, 2.2 Hz, 1H, ArH), 6.85 (d, J = 2.1 Hz, 1H, ArH), 5.23 (t, J = 
1.5 Hz, 1H, CCH2), 5.18 (q, J = 1.4 Hz, 1H, CCH2), 4.70 (s, 2H, C(O)OCH2C), 4.17 (d, J = 14.9 
Hz,1H, CCH2OTBDPS), 4.13 (d, J = 14.4 Hz, 1H, CCH2OTBDPS), 3.89 (s, 3H, OMe), 3.82 (d, J 
= 17.1 Hz, 1H, CH2), 3.40 (d, J = 17.1 Hz, 1H, CH2), 1.03 (d, J = 2.8 Hz, 30H, TIPS +tBu). 
13C NMR (101 MHz, Chloroform-d) δ 193.8, 168.0, 166.1, 155.1, 141.9, 135.5, 133.4, 129.7, 
127.7, 127.4, 126.5, 116.2, 112.9, 109.4, 103.4, 85.2, 66.2, 64.6, 56.7, 55.8, 41.2, 26.8, 19.3, 
18.6, 11.2. 
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IR νmax 2941 (m), 2893 (w), 2863 (m), 2171 (w), 1723 (s), 1601 (s), 1464 (m), 1264 (s), 1209 
(m), 1111 (s), 1094 (m), 1073 (m), 913 (m), 707 (m). 
HRMS (ESI) calcd for C42H54NaO5Si2 [M+Na] 717.3407; found 717.3408. 
2-Methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate (2k) 
Starting from 2-methylallyl 6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3k) 
(1.40 g, 5.10 mmol), 2-methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate (2k) (1.37 g, 2.55 mmol, 50% yield) was obtained as a 
colorless oil using DBU as a base and TBDPS-EBX (4b) as the reagent in the general procedure.  
RF 0.3 (dichloromethane:pentane 5:1).  
1H NMR (400 MHz, Chloroform-d) δ 8.07 (d, J = 8.8 Hz, 1H, ArH), 7.67 (ddd, J = 11.3, 8.1, 
1.4 Hz, 3H, ArH), 7.39 – 7.32 (m, 2H, ArH), 7.32 – 7.25 (m, 5H, Ph), 6.88 (dd, J = 8.8, 2.5 Hz, 
1H, ArH), 6.72 (d, J = 2.5 Hz, 1H, ArH), 5.09 (s, 1H, CMeCH2), 4.96 (s, 1H, CMeCH2), 4.77 (d, 
J = 12.9 Hz, 1H, CH2CMe), 4.71 (d, J = 12.9 Hz, 1H, CH2CMe), 3.87 (s, 3H, OMe), 3.45 (ddd, J 
= 16.7, 11.7, 4.6 Hz, 1H, CH2), 2.99 (dt, J = 16.7, 4.2 Hz, 1H, CH2), 2.84 (ddd, J = 13.3, 11.7, 4.4 
Hz, 1H, CH2), 2.55 – 2.45 (m, 1H, CH2), 1.79 (t, J = 1.1 Hz, 3H, CCH3), 0.98 (s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 188.0, 168.7, 164.1, 145.6, 139.4, 135.5, 135.5, 133.0, 
133.0, 131.3, 129.5, 127.7, 127.7, 127.6, 123.8, 113.8, 113.7, 112.5, 103.5, 87.7, 69.4, 56.5, 55.6, 
32.7, 26.9, 26.4, 19.5, 18.7. 
IR νmax 3071 (w), 2955 (w), 2931 (w), 2900 (w), 2892 (w), 2858 (w), 2165 (w), 1741 (w), 1714 
(m), 1685 (w), 1600 (s), 1429 (m), 1291 (w), 1260 (s), 1227 (w), 1109 (m), 1090 (m), 821 (w), 
741 (m). 
HRMS (ESI) calcd for C34H37O4Si+ [M+H]+ 537.2456; found 537.2452. 
2-Methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (2l) 
Starting from 2-methylallyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3l) (0.10 g, 0.41 
mmol), 2-methylallyl 2-((tert-butyldiphenylsilyl)ethynyl)-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
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carboxylate (2l) (0.096 g, 0.19 mmol, 46 % yield) was obtained as colorless oil using DBU as a 
base and TBDPS-EBX (4b) as the reagent in the general procedure. 
RF 0.32 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 8.10 (dd, J = 7.9, 1.4 Hz, 1H, ArH), 7.65 (td, J = 8.3, 1.4 
Hz, 4H, Ph), 7.54 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.39 – 7.33 (m, 3H, ArH), 7.31 – 7.24 (m, 5H, 
Ph + ArH), 5.12 – 5.07 (s, 1H, CMeCH2), 4.96 (s, 1H, CMeCH2), 4.75 (d, 1 H, J = 12.9 Hz, 1H, 
CH2CMe), 4.70 (d, 1 H, J = 12.9 Hz, 1H, CH2CMe), 3.48 (ddd, J = 18.0, 11.5, 4.7 Hz, 1H, CH2), 
3.05 (dt, J = 17.3, 4.3 Hz, 1H, CH2), 2.87 (ddd, J = 13.4, 11.5, 4.5 Hz, 1H, CH2), 2.53 (ddd, J = 
13.4, 4.7, 3.8 Hz, 1H, CH2), 1.79 (t, J = 1.2 Hz, 3H, CMe), 0.97 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ 189.2, 168.4, 143.1, 139.4, 135.5, 135.4, 134.1, 132.9, 132.9, 
130.5, 129.5, 128.8, 128.8, 127.7, 127.1, 113.6, 102.9, 88.2, 69.5, 56.6, 32.5, 26.9, 26.0, 19.5, 
18.7. Two carbon of the Ph group are not resolved. 
IR νmax 3072 (w), 2932 (w), 2892 (w), 2861 (w), 2255 (w), 2168 (w), 1740 (m), 1697 (m), 1601 
(w), 1474 (w), 1464 (w), 1430 (w), 1256 (m), 1225 (m), 1112 (m), 909 (s), 735 (s). 
HRMS (ESI) calcd for C33H34NaO3Si+ [M+Na]+ 529.2169; found 529.2151. 
Allyl 2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-
carboxylate (2m) 
Starting from allyl 6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (3m) (0.103 g, 
0.396 mmol), allyl 2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-1-oxo-1,2,3,4-
tetrahydronaphthalene-2-carboxylate (2m) (0.144 g, 0.275 mmol, 70 % yield) was obtained as 
colorless oil using DBU as a base and TBDPS-EBX (4b) as the reagent in the general procedure. 
RF 0.3 (dichloromethane:pentane 5:1).  
1H NMR (400 MHz, Chloroform-d) δ 8.06 (d, J = 8.8 Hz, 1H, ArH), 7.72 – 7.63 (m, 4H, Ph), 
7.40 – 7.32 (m, 2H, Ph), 7.29 (td, J = 6.7, 1.1 Hz, 4H, Ph), 6.88 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 
6.72 (d, J = 2.5 Hz, 1H, ArH), 5.99 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H, CHCH2), 5.42 (dd, J = 17.2, 
1.5 Hz, 1H, CHCH2), 5.26 (dq, J = 10.5, 1.3 Hz, 1H, CHCH2), 4.79 (ddt, J = 5.7, 4.2, 1.5 Hz, 2H, 
CH2CH), 3.87 (s, 3H, OMe), 3.45 (ddd, J = 16.7, 11.8, 4.6 Hz, 1H, CH2), 2.99 (dt, J = 17.1, 4.1 
Hz, 1H, CH2), 2.83 (ddd, J = 13.4, 11.7, 4.4 Hz, 1H, CH2), 2.49 (ddd, J = 13.3, 4.7, 3.9 Hz, 1H, 
CH2), 0.98 (s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 188.0, 168.7, 164.1, 145.6, 135.5, 135.5, 133.0, 133.0, 
131.6, 131.3, 129.5, 127.7, 127.7, 123.8, 118.6, 113.8, 112.5, 103.4, 87.7, 66.7, 56.4, 53.4, 32.6, 
26.9, 26.4, 18.7. One carbon of the Ph is not resolved. 
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IR νmax 2957 (w), 2956 (w), 2934 (w), 2901 (w), 2894 (w), 2859 (w), 2858 (w), 2169 (w), 1744 
(m), 1687 (m), 1601 (s), 1256 (s), 1227 (m), 1112 (m), 914 (m), 741 (m). 
HRMS (ESI) calcd for C33H34NaO4Si+ [M+Na]+ 545.2119; found 545.2128. 
2-Methylallyl 5-((tert-butyldiphenylsilyl)ethynyl)-4-oxo-4,5,6,7-tetrahydrobenzofuran-5-
carboxylate (2n) 
Starting from 2-methylallyl 4-oxo-4,5,6,7-tetrahydrobenzofuran-5-carboxylate (3n) (0.094 g, 
0.40 mmol), 2-methylallyl 5-((tert-butyldiphenylsilyl)ethynyl)-4-oxo-4,5,6,7-
tetrahydrobenzofuran-5-carboxylate (2n) (0.177 g, 0.321 mmol, 80 % yield with 66% purity) was 
obtained as a colorless oil using DBU as a base and TBDPS-EBX (4b) as the reagent in the 
general procedure. 
RF 0.4 (pentane:dichloromethyne 1:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.72 – 7.67 (m, 6H, Ph+ArH), 7.44 – 7.31 (m, 5H, Ph), 
6.77 (d, J = 2.0 Hz, 1H, ArH), 5.10 (s, 1H, CMeCH2), 4.97 (s, 1H, CMeCH2), 4.73 (d, 1 H, J = 
12.9 Hz, 1H, CH2CMe), 4.67 (d, 1 H, J = 12.9 Hz, 1H, CH2CMe), 3.33 – 3.17 (m, 1H, CH2), 3.07 
(dt, J = 17.5, 4.6 Hz, 1H, CH2), 2.93 (ddd, J = 13.4, 10.0, 5.1 Hz, 1H, CH2), 2.58 (ddd, J = 13.4, 
5.1, 3.9 Hz, 1H, CH2), 1.85 – 1.76 (m, 3H, CMe), 1.03 (s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 184.9, 168.1, 165.7, 143.3, 139.3, 135.5, 135.5, 134.8, 
132.9, 132.8, 129.7, 129.5, 127.7, 118.9, 113.8, 107.5, 103.1, 87.4, 69.6, 56.3, 49.5, 32.9, 26.9, 
26.6, 21.3. 
IR νmax 3071 (w), 2954 (w), 2931 (m), 2894 (w), 2858 (w), 1742 (w), 1695 (s), 1600 (w), 1471 
(w), 1450 (m), 1439 (w), 1429 (s), 1361 (w), 1289 (w), 1258 (w), 1240 (w), 1214 (w), 1201 (w), 
1189 (w), 1111 (s), 1010 (w), 939 (w), 925 (w), 911 (w), 877 (w), 821 (w), 741 (s). 
HRMS (ESI) calcd for C31H32O4SiK+ [M+K]+ 519.1932; found 519.1940. 
2-Methylallyl 6-((tert-butyldiphenylsilyl)ethynyl)-5-oxo-6,7,8,9-tetrahydro-5H-
benzo[7]annulene-6-carboxylate (2o) 
Starting from 2-methylallyl 5-oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulene-6-carboxylate 
(3o)(0.10 g, 0.40 mmol) 2-methylallyl 6-((tert-butyldiphenylsilyl)ethynyl)-5-oxo-6,7,8,9-
tetrahydro-5H-benzo[7]annulene-6-carboxylate (2o) (0.16 g, 0.31 mmol, 77 % yield) was 
O O
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obtained as a colorless oil using DBU as a base and TBDPS-EBX (4b) as the reagent in the 
general procedure.  
RF 0.73 (dichloromethane:pentane 1:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.64 (td, J = 8.0, 1.5 Hz, 4H, Ph), 7.51 (dd, J = 7.6, 1.4 
Hz, 1H, ArH), 7.40 (dd, J = 7.6, 1.5 Hz, 1H, ArH), 7.38 – 7.34 (m, 1H, ArH), 7.34 – 7.28 (m, 6H, 
Ph), 7.21 – 7.16 (m, 1H, ArH), 5.04 (s, 1H, CMeCH2), 4.92 (s, 1H, CMeCH2), 4.69 (d, J = 12.9 
Hz, 1H, CH2CMe), 4.64 (d, 1 H, J = 12.9 Hz, 1H, CH2CMe), 3.16 (ddd, J = 15.1, 9.5, 3.6 Hz, 1H, 
CH2), 2.88 (ddd, J = 15.1, 7.5, 4.0 Hz, 1H, CH2), 2.59 – 2.43 (m, 1H, CH2), 2.33 (tdd, J = 8.5, 
6.9, 4.5 Hz, 2H, CH2), 2.09 – 1.93 (m, 1H, CH2), 1.74 (dd, J = 1.7, 0.9 Hz, 3H, CCH3), 0.96 (s, 
9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 200.6, 168.7, 139.4, 138.8, 138.4, 135.5, 135.5, 133.0, 
132.9, 131.8, 129.5, 129.2, 128.9, 127.6, 126.8, 113.7, 104.3, 88.5, 69.5, 60.6, 34.5, 33.8, 26.9, 
23.5, 19.5, 18.6. Two carbons of the Ph group are not resolved.  
IR νmax 3071 (w), 3049 (w), 2954 (m), 2931 (m), 2893 (w), 2858 (m), 2173 (w), 1749 (s), 1694 
(s), 1660 (w), 1599 (w), 1486 (w), 1471 (w), 1461 (w), 1449 (m), 1430 (m), 1390 (w), 1362 (w), 
1250 (m), 1213 (s), 1170 (w), 1110 (s), 1031 (w), 1009 (w), 973 (w), 954 (m), 910 (m), 821 (m), 
802 (w), 776 (w), 764 (w), 741 (s). 
HRMS (ESI) calcd for C34H37O3Si+ [M+H]+ 521.2506; found 521.2502.
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5. Pd-Catalyzed decarboxylation of allyl β-keto esters. 
5.1 Synthesis of Pd(cinnamyl)Cp 
Pd(cinnamyl)Cp (6) 
 
Following a reported procedure,12 in a 2-neck 25 mL flask cinnamylpalladium(II) chloride (23) 
(0.300 g, 1.15 mmol) was dissolved in THF (10 mL). The solution was cooled to -78 °C. A 
solution of cyclopenta-2,4-dien-1-ylsodium (22) (1.45 mL, 2.90 mmol) in THF (10 ml) was 
added dropwise. The solution was stirred at -78 °C for 5 min. It was then allowed to warm to 
room temperature and then cooled again to 0 °C. The solvent was removed from the cooled 
solution with the high vac. and hexane was added. The dissolved solids were filtered and the 
filtrated was concentrated in vacuo to obtain an oily purple solid. Upon addition of hexane (1.5 
mL) crystallization took place at -40 °C to afford cyclopenta-2,4-dien-1-yl(3-
phenylpropyl)palladium (6) (0.300 g, 1.04 mmol, 90% yield) as purple cristals. 
1H NMR (400 MHz, Chloroform-d) δ 7.47 (m, 2H, CpCH), 7.24 (m, 2H, CpCH), 5.65 (s, 5H, 
Ph), 5.49 (ddd, 1 H, J = 10.6, 9.9, 6.2 Hz, CH), 4.09 (d, 1 H, J = 9.8 Hz, CH), 3.63 (d, 1 H, J = 
6.2 Hz, CH2), 2.38 (dd, 1 H, J = 10.6, 0.7 Hz, CH2). 
The characterization data for compounds 11 corresponded to the reported values.12 
5.2 General procedure for the asymmetric decarboxylation catalyzed by Pd. 
 
                                                 
(12) A.W. Fraser, J.E. Besaw, L.E. Hull, M.C. Baird, Organometallics 2012, 31, 2470. 
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Substrate 7 (0.123 mmol), Pd(cinnamyl)Cp (6) (2 mol%) and ligand 5e (2.5 mol%) were placed 
in a micro wave vial which was sealed. The solvent MTBE (1.2 mL) was added and the reaction 
was immediately degased three times. The mixture was left stirring at room temperature and 
monitored by TLC. Upon completeness the reaction was filtered through a plug of silica and the 
solvent evaporated. Purification by column chromatography yielded the product that was 
analyzed by chiral HPLC. The procedure used for optimization and scope are the same. (see 
Table 1 on main manuscript for optimization procedure). 
Entry Reaction conditionsa L eeb 
1 [Pd2(dba)3], THF 5a 0 
2 [Pd(cinnamyl)Cp] (6), THF 5a 0 
3 6, THF 5b 0 
4 6, Et2O 5b 12 
5 6, Et2O 5c 59 
6 6, Toluene 5c 28 
7 6, CH2Cl2 5c 3 
8 6, CH3CN 5c 11 
9 6, 1,4-dioxane 5c 29 
10 6, Et2O 5d 76 
11 6, Et2O 5e 74 
12 6, MTBE 5d 70 
13 6, MTBE 5e 79 
14 6, MTBE, 0°C 5e 77 
15 6, MTBE, 0.1 M 5e 86 
16 6, MTBE, 0.3 M 5e 83 
17 5 mol% 6/ 5 mol% L, MTBE, 0.1 M 5e 86 
18 5 mol% 6/ 10 mol% L, MTBE, 0.1 M 5e 84 
19 2 mol% 6/ 5 mol% L, MTBE, 0.1 Mc 5e 93 
aAll the reaction mixtures were degased three times and stirred at room temperature for 8-12 h using substrate 2a (0.01 mmol), the 
indicated solvent (0.033 M), Pd source (20 mol%) and ligand (44 mol%) unless stated otherwise. All the reactions gave full 
conversion to the desired product 1a. bThe ee was determined by HPLC using Chiralcel columns. cSubstrate 2b was used. 
(S)-2-Allyl-5-methoxy-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1a) 
Starting from substrate 2a (0.052 g, 0.12 mmol), 2-allyl-5-methoxy-2-((triisopropylsilyl)ethynyl)-
2,3-dihydro-1H-inden-1-one (1a) (0.047 g, 0.12 mmol, 99% yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 89%.Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 7.1 
min and tR2 = 9.3 min. λ = 254 cm-1. 
O
TIPSMeO
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RF 0.7 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.72 (d, J = 8.5 Hz, 1H, ArH), 6.92 (dd, J = 8.5, 2.3 Hz, 
1H, ArH), 6.84 (d, J = 2.3 Hz, 1H, ArH), 5.89 (dddd, J = 16.7, 10.1, 7.8, 6.5 Hz, 1H, CHCH2), 
5.17 – 5.06 (m, 2H, CHCH2), 3.88 (s, 3H, OCH3), 3.30 (d, 1 H, J = 17.3 Hz, 1H, CH2), 3.22 (d, J 
= 17.3 Hz, 1H, CH2), 2.69 (ddt, J = 13.6, 6.5, 1.4 Hz, 1H, CH2CH), 2.34 (dd, J = 13.7, 7.8 Hz, 
1H, CH2CH), 1.04 (s, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 200.9, 165.8, 154.7, 133.6, 127.8, 126.7, 118.7, 115.8, 109.6, 
108.6, 82.8, 55.7, 49.0, 42.8, 40.4, 18.6, 11.2. 
IR νmax 3071 (w), 3049 (w), 2954 (m), 2931 (m), 2893 (w), 2858 (m), 2173 (w), 1749 (s), 1694 
(s), 1660 (w), 1599 (w), 1486 (w), 1471 (w), 1461 (w), 1449 (m), 1430 (m), 1390 (w), 1362 (w), 
1250 (m), 1213 (s), 1170 (w), 1110 (s), 1031 (w), 1009 (w), 973 (w), 954 (m), 910 (m), 821 (m), 
802 (w), 776 (w), 764 (w), 741 (s). 
HRMS (ESI) calcd for C24H35O2Si+ [M+H]+ 383.2401; found 383.2399. 
[α]D25.0 +20.9 (c = 3.78, CHCl3). 
(S)-5-Methoxy-2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one 
(1b) 
Starting from substrate 2b (54 mg, 0.12 mmol) (S)-5-methoxy-2-(2-methylallyl)-2-
((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1b) (49 mg, 0.12 mmol, 99% yield) was 
obtained as a yellow oil.  
Chiral HPLC conditions. ee: 93%/95%13; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 15 min. 
tR1 = 6.4 min and tR2 = 9.4 min. λ = 254 cm-1. 
RF 0.88 (pentane:ethyl acetate 9:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.5 Hz, 1H, ArH), 6.92 (dd, J = 8.5, 2.3 Hz, 
1H, ArH), 6.85 (d, J = 2.2 Hz, 1H, ArH), 4.86 (s, 1H, CCH2), 4.80 (s, 1H, CCH2), 3.89 (s, 3H, 
OCH3), 3.37 (d, 1 H, J = 17.3 Hz, 1H, CH2), 3.31 (d, 1 H, J = 17.3 Hz, 1H, CH2). 2.77 – 2.68 (d, 
J = 13.9 Hz, 1H, CH2CMe), 2.38 – 2.29 (d, J = 14.0 Hz, 1H, CH2CMe), 1.82 (t, J = 1.1 Hz, 3H, 
CCH3), 1.01 (s, 21H, CTIPS). 
13C NMR (101 MHz, CDCl3) δ 201.0, 165.7, 154.8, 142.2, 127.5, 126.9, 115.7, 114.9, 109.6, 
109.4, 82.7, 55.7, 48.7, 45.3, 40.6, 23.7, 18.6, 17.7, 12.3, 11.2. 
                                                 
13 Obtained for the larger scale reaction. 
O TIPS
MeO
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IR νmax 2942 (w), 2923 (w), 2892 (w), 2864 (m), 2161 (w), 1716 (s), 1600 (s), 1491 (w), 1463 
(m), 1447 (w), 1382 (w), 1336 (w), 1296 (m), 1209 (w), 1186 (w), 1147 (w), 1103 (m), 1091 (s), 
1028 (m), 997 (m), 965 (w), 933 (m), 909 (s), 884 (s), 845 (m), 820 (m), 787 (w), 757 (w), 734 
(s).  
HRMS (ESI) calcd for C25H37O2Si+ [M+H]+ 397.2557; found 397.2564. 
[α]D25.0 +80.5 (c = 2.75, CHCl3). 
(S)-2-((Tert-butyldiphenylsilyl)ethynyl)-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-
1-one (1c) 
Following the general procedure and starting from substrate 2c  (0.070 g, 0.13 mmol) (S)-2-
((Tert-butyldiphenylsilyl)ethynyl)-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (1c) 
(0.064 g, 0.12 mmol, quantitative yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 91%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 30 min tR1 = 
5.6 min and tR2 = 8.0 min. λ = 280 cm-1. 
RF 0.4 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ  7.85 – 7.69 (m, 5H, ArH), 7.43 – 7.30 (m, 6H, ArH), 7.03 
– 6.84 (dd, 2 H, J = 8.5, 2.0 Hz, ArH), 4.93 (s, 1H, CCH2), 4.90 (s, 1H, CCH2), 3.89 (s, 3H, O 
CH3), 3.49 (d, 1 H, J = 17.5 Hz, 1H, CH2), 3.44 (d, 1 H, J = 17.5 Hz, 1H, CH2), 2.91 (d, J = 14.1, 
1H, CH2CMe), 2.50 (d, J = 14.2 Hz, 1H, CH2CMe), 1.86 (s, 3H, CCH3), 1.05 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ 200.5, 165.9, 154.8, 141.9, 135.6, 133.5, 133.4, 129.4, 127.6, 
127.4, 127.0, 115.9, 115.2, 111.8, 109.7, 82.0, 55.7, 49.0, 45.3, 40.4, 27.1, 23.8, 18.7.[14] 
IR νmax 3072 (w), 3052 (w), 2999 (w), 2957 (w), 2929 (w), 2898 (w), 2857 (w), 2162 (w), 1714 
(m), 1676 (w), 1646 (w), 1599 (s), 1490 (w), 1470 (w), 1463 (w), 1447 (w), 1429 (m), 1362 (w), 
1336 (w), 1293 (w), 1262 (s), 1148 (w), 1106 (m), 1090 (m), 1028 (w), 1011 (w), 1000 (w), 934 
(w), 908 (s), 847 (w), 821 (m), 786 (w), 766 (w), 733 (s). 
HRMS (ESI) calcd for C32H35O2Si+ [M+H]+ 479.2401; found 479.2397. 
[α]D25.0 +72.9 (c = 3.49, CHCl3). 
(S)-2-Ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (1d) 
                                                 
(14) Not all the carbon of the phenyl rings are resolved. 
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Following the general procedure and starting from .substrate 2d (0.038 g, 0.13 mmol), 2-ethynyl-
5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (1d) (0.013 g, 0.054 mmol, 41 % 
yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 87%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 30 min.. tR1 = 
20.7 min and tR2 = 25.3 min. λ = 254 cm-1 
 
From Product 1b: 
 
Following a reported procedure,15 TBAF (2.54 mL, 2.54 mmol, 1 M in Et2O, 2.0 equiv.) was 
added dropwise to a solution of compound 1b (0.503 g, 1.27 mmol) in THF (16 mL) at room 
temperature. The reaction was monitored by TLC (8:2 pentane/ethyl acetate). The reaction is 
quenched with a saturated solution of NH4Cl (5 mL) and extracted twice with Et2O (2 x 10 mL). 
The organic layers were combined, washed with saturated NaHCO3 (10 mL), brine (10 mL), 
dried over MgSO4 and concentrated under reduced pressure. The crude mixture was purified by 
flask chromatography (pentane/ethyl acetate 8:2) to afford compound 1d (0.304 g, 1.27 mmol, 
<99% yield/95% ee) as a yellow oil. 
 
In one pot from 2b:  
Starting from substrate 2b (4.38 g, 9.94 mmol) 2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-
dihydro-1H-inden-1-one (1d) (1.98 g, 8.24 mmol, 83% yield/95% ee) was obtained as a yellow 
oil. TBAF (19.8 mL, 19.8 mmol, 2.00 equiv.) was added directly to the reaction mixture after 
completion of the allylation step. 
 
RF 0.3 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.5 Hz, 1H, ArH), 6.92 (ddd, J = 8.5, 1.9, 1.0 
Hz, 1H, ArH), 6.85 (dt, J = 2.1, 1.0 Hz, 1H, ArH), 4.88 (s, 1H, CMeCH2), 4.81 (s, 1H, CMeCH2), 
3.88 (s, 3H, OMe), 3.38 (d, 1 H, J = 17.5 Hz, 1H, CH2), 3.32 (d, 1 H, J = 17.5 Hz, 1H, CH2), 2.72 
(dd, J = 14.2, 1.1 Hz, 1H, CH2CMe), 2.36 (dd, J = 14.1, 1.1 Hz, 1H, CH2CMe), 2.22 (s, 1H, 
CCH), 1.79 (dd, J = 1.5, 0.8 Hz, 3H, CMe). 
13C NMR (101 MHz, CDCl3) δ 201.1, 166.0, 154.9, 141.8, 127.2, 126.9, 116.0, 115.2, 109.6, 
85.6, 70.5, 55.7, 47.5, 45.1, 39.8, 23.7. 
                                                 
[15] X. Wang, T. Yang, X. Cheng, Q. Shen, Angew. Chem. Int. Ed. 2013, 52, 12860-12864. 
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IR νmax 3302 (w), 2945 (w), 2944 (w), 2843 (w), 2253 (w), 1710 (m), 1600 (m), 1264 (m), 907 
(s), 730 (s). 
HRMS (ESI) calcd for C16H17O2+ [M+H]+ 241.1223; found 241.1222. 
[α]D25.0 +104.1 (c = 2.17, CHCl3). 
(S)-2-(2-Methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1e) 
Following the general procedure and starting from substrate 2e (51 mg, 0.12 mmol) 2-(2-
methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1e) (0.045 g, 0.13 mmol, 
quantitative yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 94%; Chiralcel IF 99.9:0.1 Hexane/iPrOH, 1 mL/min, 20 min. tR1 
= 12.8 min and tR2 = 14.7 min. λ = 230 cm-1. 
RF 0.3 (dichloromethane:pentane 5:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.80 (d, J = 7.6 Hz, 1H, ArH), 7.62 (td, J = 7.5, 1.2 Hz, 
1H, ArH), 7.46 – 7.37 (m, 2H, ArH), 4.87 (s, 1H, CMeCH2), 4.80 (s, 1H, CMeCH2), 3.42 (d, 1 H, 
J = 17.4 Hz, 1H, CH2), 3.37 (d, 1 H, J = 17.5 Hz, 1H, CH2), 2.74 (dd, J = 14.1, 1.1 Hz, 1H, 
CH2CMe), 2.35 (dd, J = 14.1, 1.1 Hz, 1H, CH2CMe), 1.83 (s, 3H, CMeCH2), 1.01 (s, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 202.8, 151.8, 142.0, 135.2, 134.4, 127.7, 126.5, 125.2, 115.0, 
109.0, 83.1, 48.6, 45.1, 40.6, 23.7, 18.6, 11.2. 
IR νmax 2943 (s), 2892 (w), 2865 (s), 2161 (w), 1923 (w), 1728 (s), 1686 (w), 1610 (w), 1464 
(m), 1436 (w), 1297 (w), 1262 (w), 1017 (w), 997 (w), 928 (w), 886 (m), 784 (w), 737 (s). 
HRMS (ESI) calcd for C24H35OSi+ [M+H]+ 367.2452; found 367.2452. 
[α]D25.0 +20.0 (c = 2.58, CHCl3). 
(S)-5-Bromo-2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one 
(1f) 
Following the general procedure and starting from substrate 2f (60 mg, 0.12 mmol) 5-bromo-2-
(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1f) (0.041 g, 0.092 
mmol, 77 % yield) was obtained as a yellow oil.  
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Chiral HPLC conditions: ee: 85%; Chiralcel IF 99:1 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 
12.8 min and tR2 = 13.8 min. λ = 254 cm-1. 
RF 0.43 (dichloromethane:pentane 1:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.50 (d, J = 8.2 Hz, 1H, ArH), 7.46 (d, J = 1.6 Hz, 1H, 
ArH), 7.38 (dd, J = 8.2, 1.6 Hz, 1H, ArH), 4.74 – 4.69 (m, 1H, CCH2), 4.63 (dd, J = 2.2, 1.2 Hz, 
1H, CCH2), 3.39 (d, J = 17.4 Hz, 1H, CH2), 3.34 (d, J = 17.4 Hz, 1H, CH2), 2.57 (dd, J = 14.1, 
1.1 Hz, 1H, CH2CMe), 2.20 (dd, J = 14.1, 1.1 Hz, 1H, CH2CMe), 1.69 – 1.62 (m, 3H, CCH3), 
0.85 (s, 21H, CTIPS). 
13C NMR (101 MHz, CDCl3) δ. 201.5, 153.4, 141.7, 133.2, 131.4, 130.6, 129.8, 126.3, 115.3, 
108.4, 83.6, 48.6, 45.1, 40.2, 23.7, 18.6, 11.2.  
IR νmax 2943 (m), 2943 (m), 2891 (w), 2891 (w), 2865 (m), 2865 (m), 2162 (w), 1730 (s), 1597 
(s), 1579 (w), 1579 (w), 1464 (w), 1464 (w), 1432 (w), 1415 (w), 1313 (w), 1313 (w), 1261 (w), 
1261 (w), 1205 (w), 1205 (w), 1061 (w), 1061 (w), 1017 (w), 997 (w), 997 (w), 885 (m), 885 
(m), 863 (w), 817 (w), 817 (w), 779 (w), 745 (w), 733 (w).  
HRMS (ESI) calcd for C2479BrH34OSi+ [M+H]+ 445.1557; found 445.1570. 
[α]D25.0 +68.8 (c = 2.63, CHCl3). 
(S)-6-Chloro-2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one 
(6g) 
Following the general procedure and starting from substrate 2g (55 mg, 0.12 mmol) (S)-6-chloro-
2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1g) (0.037 g, 0.092 
mmol, 77 % yield) was obtained as a yellow oil using 5 mol% Pd and 6.5 mol% of ligand. 
Chiral HPLC conditions: ee: 90%; Chiralcel IF 99.9:0.1 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 
11.6 min and tR2 = 12.4 min. λ = 254 cm-1. 
RF 0.4 (dichloromethane:pentane 1:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.69 (d, J = 2.0 Hz, 1H, ArH), 7.50 (dd, J = 8.1, 2.1 Hz, 
1H, ArH), 7.31 (dd, J = 8.1, 0.9 Hz, 1H, ArH), 4.80 (t, J = 1.7 Hz, 1H, CCH2), 4.72 (dd, J = 2.2, 
1.1 Hz, 1H, CMeCH2), 3.37 (d, 1 H, J = 17.4 Hz, 1H, CH2), 3.32 (d, 1 H, J = 17.4 Hz, 1H, CH2), 
2.65 (dd, J = 14.1, 1.1 Hz, 1H, CH2CMe), 2.29 (dd, J = 14.0, 1.1 Hz, 1H, CH2CMe), 1.74 (t, J = 
1.1 Hz, 3H, CCH3), 0.94 (m, 21H, CTIPS). 
13C NMR (101 MHz, CDCl3) δ. 201.5, 149.8, 141.7, 135.9, 135.3, 134.1, 127.7, 124.9, 115.3, 
108.3, 83.6, 49.2, 45.1, 40.2, 23.7, 18.6, 11.2. 
IR νmax 2943 (s), 2892 (w), 2865 (s), 2162 (w), 1730 (s), 1466 (m), 1250 (m), 1183 (m), 885 (s), 
819 (m). 
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HRMS (ESI) calcd for C24ClH34OSi+ [M+H]+ 401.2062; found 401.2054. 
[α]D25.0 -1.98 (c = 2.82, CHCl3). 
(R)-2-(2-Methylallyl)-6-(trifluoromethyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
inden-1-one (1h) 
Following the general procedure and starting from substrate 2h (63 mg, 0.13 mmol), (S)-2-(2-
Methylallyl)-6-(trifluoromethyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1h) 
(42 mg, 0.097 mmol, 79% yield) was obtained as a yellow oil.16 
Chiral HPLC conditions: ee: 73%; Chiralcel IC 99.9:0.1 Hexane/iPrOH, 1 mL/min, 20 min tR1 
= 5.4 min and tR2 = 5.9 min, λ = 280 cm-1. 
RF 0.25 (dichloromethane:pentane 1:5). 
1H NMR (400 MHz, Chloroform-d) δ 8.07 (s, 1H, ArH), 7.86 (dd, J = 8.0, 1.9 Hz, 1H, ArH), 
7.58 (d, J = 8.0 Hz, 1H, ArH), 4.89 (s, 1H, CMeCH2), 4.80 (s, 1H, CMeCH2), 3.49 (d, 1 H, J = 
17.8 Hz, 1H, CH2), 3.42 (d, 1 H, J = 17.9 Hz, 1H, CH2), 2.75 (d, J = 14.1 Hz, 1H, CH2CMe), 
2.38 (d, J = 14.1 Hz, 1H, CH2CMe), 1.83 (s, 3H, CCH3), 1.01 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) δ 201.5, 155.0, 141.6, 134.9, 131.7 (q, J = 3.5 Hz), 130.69 
(q, J = 33.0 Hz), 127.3, 123.7 (q, J = 273.0 Hz), 122.4 (q, J = 4.2 Hz), 115.4, 108.0, 84.0, 48.93, 
45.0, 40.6, 23.7, 18.6, 11.2. 
19F NMR (376 MHz, Chloroform-d) δ -62.5. 
IR νmax 2944 (w), 2893 (w), 2866 (w), 2163 (w), 1733 (m), 1626 (w), 1331 (s), 1251 (m), 1200 
(w), 1183 (m), 1170 (m), 1134 (s), 909 (m), 885 (m), 825 (w), 735 (s). 
HRMS (ESI) calcd for C25F3H34OSi+ [M+H]+ 435.2326; found 435.2330. 
[α]D25.0 +6.28 (c = 3.42, CHCl3). 
(R)-2-(2-Chloroallyl)-5-methoxy-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one 
(1i) 
                                                 
16 The other enantiomer of the ligand (S enantiomer) was used due to HPLC separation issues 
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Following the general procedure and starting from substrate 2i (57 mg, 0.12 mmol) (S)-2-(2-
chloroallyl)-5-methoxy-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1i) (0.041 g, 
0.098 mmol, 80 % yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 90%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 
6.0 min and tR2 = 6.7 min. λ = 280 cm-1. 
RF 0.45 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.58 (d, J = 8.5 Hz, 1H, ArH), 6.78 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.73 (d, J = 2.2 Hz, 1H, ArH), 5.24 (s, 1H, CCH2), 5.17 (s, 1H, CCH2), 3.74 (s, 3H, 
OCH3), 3.44 (d, J = 17.4 Hz, 1H, CH2), 3.28 (d, J = 17.4 Hz, 1H, CH2), 2.92 (d, J = 14.8 Hz, 1H, 
CH2CMe), 2.50 (dd, J = 14.8, 1.0 Hz, 1H, CH2CMe), 0.85 (m, 21H, CTIPS). 
13C NMR (101 MHz, CDCl3) δ 199.8, 165.9, 155.0, 137.8, 127.3, 126.9, 116.7, 115.9, 109.6, 
107.6, 83.6, 55.7, 49.2, 45.8, 41.1, 18.6, 11.2. 
IR νmax 2944 (m), 2893 (w), 2865 (m), 2163 (w), 1716 (s), 1601 (s), 1464 (m), 1297 (m), 1026 
(m), 997 (w), 884 (s), 869 (m), 846 (m), 771 (m). 
HRMS (ESI) calcd for C24H33ClNaO2Si+ [M+Na]+ 439.1831; found 439.1835. 
[α]D25.0 +116.9 (c = 3.058, CHCl3). 
(R)-2-(2-(((Tert-butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-2-
((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (1j) 
Following the general procedure and starting from substrate 2j (78 mg, 0.11 mmol), 2-(2-(((tert-
butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
inden-1-one (1j) (0.062 g, 0.095 mmol, 85 % yield) was obtained as a yellow oil using 5 mol% of 
Pd and 6.5 mol% of ligand. 
Chiral HPLC conditions: ee: 94%; Chiralcel IF 99:1 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 7.9 
min and tR2 = 9.3 min. λ = 254 cm-1. 
RF 0.53 (pentane:ethylacetate 9:1). 
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1H NMR (400 MHz, Chloroform-d) δ 7.71 – 7.60 (m, 5H, Ph), 7.45 – 7.39 (m, 2H, ArH), 7.35 
(tdd, J = 6.8, 3.7, 1.6 Hz, 4H, Ph), 6.90 (dd, J = 8.5, 2.4 Hz, 1H, ArH), 6.79 (d, J = 2.2 Hz, 1H, 
ArH), 5.37 (s, 1H, CCH2), 5.10 (s, 1H, CCH2), 4.28 (d, 1 H, J = 14.6 Hz, 1H, CH2OTIPS), 4.10 
(d, 1 H, J = 14.6 Hz, 1H, CH2OTIPS), 3.88 (s, 3H, OMe), 3.31 (d, 1 H, J = 17.3 Hz, 1H, CH2), 
3.21 (d, 1 H, J = 17.3 Hz, 1H, CH2), 2.70 (d, J = 14.6 Hz, 1H, CH2CH2), 2.35 (d, J = 14.6 Hz, 
1H, CH2CH2), 1.03 (d, J = 2.5 Hz, 9H, tBu), 0.93 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 200.9, 165.7, 154.8, 144.0, 135.5, 133.6, 133.5, 129.6, 127.6, 
127.4, 126.8, 115.7, 113.3, 109.6, 109.2, 82.8, 66.7, 55.7, 48.7, 40.6, 40.5, 26.8, 19.3, 18.6, 
11.1.[13] 
IR νmax 2956 (m), 2942 (m), 2892 (w), 2863 (m), 2161 (w), 1718 (s), 1601 (s), 1464 (w), 1293 
(w), 1263 (s), 1112 (s), 909 (w), 826 (w), 741 (w), 705 (s). 
HRMS (ESI) calcd for C41H54NaO3Si2+ [M+Na]+ 673.3504; found 673.3503. 
[α]D25.0 +44.3 (c = 1.17, CHCl3). 
(R)-2-((Tert-butyldiphenylsilyl)ethynyl)-6-methoxy-2-(2-methylallyl)-3,4-
dihydronaphthalen-1(2H)-one (1k) 
Following the general procedure and starting from substrate 2k (69 mg, 0.13 mmol) 2-((tert-
butyldiphenylsilyl)ethynyl)-6-methoxy-2-(2-methylallyl)-3,4-dihydronaphthalen-1(2H)-one (1k) 
(0.062 g, 0.13 mmol, 98 % yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 97%; Chiralcel IF 99:1 Hexane/iPrOH, 1 mL/min, 20 min tR1 =  
9.8 min; tR2 = 11.1 min. λ = 280 cm-1. 
RF 0.52 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 8.09 (d, J = 8.7 Hz, 1H, ArH), 7.63 (ddt, J = 9.9, 6.7, 1.6 
Hz, 4H, Ph), 7.39 – 7.31 (m, 2H, Ph), 7.27 (ddd, J = 8.4, 6.6, 5.0 Hz, 4H, Ph), 6.88 (dd, J = 8.8, 
2.6 Hz, 1H, ArH), 6.71 (d, J = 2.5 Hz, 1H, ArH), 4.93 (s, 1H, CCH2), 4.91 – 4.82 (m, 1H, CCH2), 
3.87 (s, 3H, OCH3), 3.47 (td, J = 12.3, 6.1 Hz, 1H, CH2), 2.99 (d, J = 13.8 Hz, 1H, CH2CMe), 
2.96 – 2.87 (m, 1H, CH2), 2.63 (d, J = 13.8 Hz, 1H, CH2CMe), 2.45 – 2.30 (m, 1H, CH2), 2.11 – 
1.96 (m, 1H, CH2), 1.92 (s, 3H, CH3), 0.96 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ. 192.7, 163.7, 146.0, 142.0, 135.5, 135.4, 133.4, 133.3, 131.1, 
129.4, 127.6, 127.6, 124.8, 115.4, 113.5, 112.3, 109.9, 85.2, 55.5, 46.2, 43.5, 32.9, 27.1, 26.9, 
24.3, 18.6.[13] 
IR νmax 3072 (w), 3050 (w), 3013 (w), 3000 (w), 2956 (w), 2948 (w), 2931 (m), 2894 (w), 2858 
(w), 2160 (w), 1713 (w), 1684 (m), 1645 (w), 1600 (s), 1573 (w), 1494 (w), 1463 (w), 1446 (w), 
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1429 (m), 1360 (w), 1346 (w), 1269 (s), 1255 (s), 1221 (m), 1159 (w), 1158 (w), 1129 (w), 1109 
(s), 1031 (w), 1009 (w), 999 (w), 970 (w), 937 (w), 908 (m), 851 (w), 821 (w), 806 (w), 740 (m). 
HRMS (ESI) calcd for C33H37O2Si+ [M+H]+ 493.2557; found 493.2551. 
[α]D25.0 -11.2 (c = 2.19, CHCl3). 
(R)-2-((Tert-butyldiphenylsilyl)ethynyl)-2-(2-methylallyl)-3,4-dihydronaphthalen-1(2H)-one 
(1l) 
Following the general procedure and starting from substrate 2l (62 mg, 0.12 mmol) 2-((tert-
butyldiphenylsilyl)ethynyl)-2-(2-methylallyl)-3,4-dihydronaphthalen-1(2H)-one (1l) (0.049 g, 
0.11 mmol, 86 % yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 96%; Chiralcel IF 99.9:0.1 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 
15.4 min; tR2 = 18.7 min. λ = 254 cm-1. 
RF 0.6 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 8.00 (dd, J = 8.0, 1.4 Hz, 1H, ArH), 7.49 (ddd, J = 8.2, 
6.7, 1.5 Hz, 4H, Ph), 7.40 (td, J = 7.5, 1.5 Hz, 1H, ArH), 7.29 - 7.23 (m, 3H, Ph), 7.19 – 7.10 (d, 
5H, Ph), 4.83 (s, 1H, CCH2), 4.76 (s, 1H, CCH2), 3.38 (td, J = 12.2, 6.0 Hz, 1H, CH2), 2.92 (m, 
1H, CH2CMe), 2.89 (dt, J = 17.2, 6.9 Hz, 1H, CH2), 2.52 (d, J = 13.8 Hz, 1H, CH2CMe), 2.30 
(ddd, J = 13.5, 4.7, 3.3 Hz, 1H, CH2), 1.93 (ddd, J = 13.4, 12.0, 4.5 Hz, 1H, CH2), 1.81 (s, 3H, 
CCH2), 0.83 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ. 193.9, 143.5, 141.9, 135.4, 135.4, 133.4, 133.4, 133.2, 131.3, 
129.4, 128.7, 128.7, 127.6, 126.8, 115.5, 109.2, 85.8, 46.5, 43.3, 32.8, 26.9, 26.6, 24.3, 18.6.[13] 
IR νmax 3071 (w), 3051 (w), 2956 (m), 2930 (m), 2893 (w), 2858 (w), 2161 (w), 1694 (s), 1647 
(w), 1600 (w), 1487 (w), 1471 (w), 1455 (m), 1429 (m), 1390 (w), 1378 (w), 1361 (w), 1336 (w), 
1292 (w), 1253 (w), 1229 (m), 1195 (w), 1158 (w), 1110 (s), 1031 (w), 1009 (w), 1000 (w), 970 
(w), 933 (w), 907 (m), 821 (m), 778 (w), 742 (s). 
HRMS (ESI) calcd for C32H35OSi+ [M+H]+ 463.2452; found 463.2446. 
[α]D25.0 -68.2 (c = 2.78, CHCl3). 
(R)-2-Allyl-2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-3,4-dihydronaphthalen-1(2H)-
one (1m) 
S40 
 
Following the general procedure and starting from substrate 2m (64 mg, 0.12 mmol) 2-allyl-2-
((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one (1m) (0.056 g, 
0.12 mmol, 95 % yield) was obtained as a yellow oil. 
Chiral HPLC conditions: ee 90%; Chiralcel IF 95:5 Hexane/iPrOH, 1 mL/min, 10 min tR1 = 
10.1 min; tR2 = 11.2 min. λ = 280 cm-1. 
RF 0.47 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 8.08 (d, J = 8.8 Hz, 1H, ArH), 7.68 – 7.64 (m, 5H, Ph), 
7.44 – 7.21 (m, 5H, Ph), 6.87 (dd, J = 8.8, 2.5 Hz, 1H, ArH), 6.71 (d, J = 2.6 Hz, 1H, ArH), 6.13 
– 5.95 (m, 1H, CHCH2), 5.27 – 5.14 (m, 2H, CCH2), 3.87 (s, 3H, OCH3), 3.46 (ddd, J = 16.8, 
11.9, 4.6 Hz, 1H, CH2), 3.02 (dd, J = 13.9, 6.6 Hz, 1 H, CH2CH), 2.95 (dt, 1 H, J = 17.1, 3.9 Hz, 
CH2), 2.57 (dd, J = 13.9, 8.0 Hz, 1H, CH2CH), 2.38 (dt, J = 13.3, 4.1 Hz, 1 H, CH2), 2.16 – 2.00 
(m, 1H, CH2), 0.98 (s, 9H, tBu).  
13C NMR (101 MHz, CDCl3) δ. 192.7, 163.7, 146.1, 135.5, 135.5, 134.0, 133.3, 131.0, 129.4, 
127.6, 127.6, 124.9, 118.7, 113.5, 112.4, 109.2, 84.8, 55.5, 47.0, 40.5, 33.3, 27.0, 26.9, 18.6.[13] 
IR νmax 3071 (w), 3050 (w), 3014 (w), 3009 (w), 3001 (w), 2956 (w), 2931 (w), 2894 (w), 2857 
(w), 2161 (w), 1683 (m), 1600 (s), 1494 (w), 1470 (w), 1464 (w), 1429 (m), 1346 (w), 1269 (s), 
1253 (s), 1221 (m), 1109 (m), 1031 (w), 998 (w), 910 (m), 820 (m), 738 (s). 
HRMS (ESI) calcd for C32H35O2Si+ [M+H]+ 479.2401; found 479.2408. 
[α]D25.0 -21.9 (c = 2.69, CHCl3). 
(R)-5-((Tert-butyldiphenylsilyl)ethynyl)-5-(2-methylallyl)-6,7-dihydrobenzofuran-4(5H)-one 
(1n) 
Following the general procedure and starting from substrate 2n (68 mg, 0.14 mmol) (S)-5-((tert-
butyldiphenylsilyl)ethynyl)-5-(2-methylallyl)-6,7-dihydrobenzofuran-4(5H)-one (1n) (0.051 g, 
0.11 mmol, 82 % yield) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 90%; Chiralcel IF 99:1 Hexane/iPrOH, 1 mL/min, 20 min. tR1 = 
7.2 min; tR2 = 7.9 min. λ = 254 cm-1. 
RF 0.51 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.66 (ddt, J = 9.4, 6.8, 1.6 Hz, 4H, Ph), 7.39 – 7.28 (m, 
7H, Ph+ArH), 6.75 (d, J = 2.1 Hz, 1H, ArH), 4.93 (s, 1H, CCH2), 4.85 (s, 1H, CCH2), 3.23 (ddd, 
J = 16.7, 11.0, 5.1 Hz, 1H, CH2), 3.02 – 2.84 (m, 1H, CH2), 2.93 (d, J = 14.0 Hz, 1H, CH2CMe), 
2.63 (d, J = 13.8 Hz, 1H, CH2CMe), 2.42 (ddd, J = 13.5, 5.1, 3.1 Hz, 1H, CH2), 2.10 (ddd, J = 
13.5, 11.0, 5.1 Hz, 1H, CH2), 1.90 (s, 3H, CCH3), 0.98 (s, 9H, tBu). 
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13C NMR (101 MHz, Chloroform-d) δ. 189.8, 165.8, 143.1, 141.9, 135.5, 135.4, 133.3, 133.2, 
129.4, 127.7, 119.4, 115.6, 109.4, 107.6, 84.9, 46.4, 42.8, 33.0, 26.9, 24.2, 21.7, 18.6.[13] 
IR νmax 3072 (w), 2954 (w), 2930 (m), 2893 (w), 2858 (w), 2161 (w), 1692 (s), 1601 (w), 1471 
(w), 1449 (w), 1429 (m), 1110 (s), 1026 (w), 1009 (w), 1000 (w), 899 (w), 878 (w), 821 (w), 808 
(w), 739 (s).  
HRMS (ESI) calcd for C30H33O2Si+ [M+H]+ 453.2244; found 453.2242. 
[α]D25.0 -58.2 (c = 1.34, CHCl3). 
(S)-6-((Tert-butyldiphenylsilyl)ethynyl)-6-(2-methylallyl)-6,7,8,9-tetrahydro-5H-
benzo[7]annulen-5-one (1o) 
Following the general procedure and starting from substrate 2o (65 mg, 0.13 mmol),  (S)-6-((tert-
butyldiphenylsilyl)ethynyl)-6-(2-methylallyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one (1o) 
(0.054 g, 0.11 mmol, 91 % yield) was obtained as a yellow oil.14  
RF 0.73 (dichloromethane:pentane 1:1). 
Chiral HPLC conditions: ee: 90%; Chiralcel IF 99:1 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 6.4 
min and tR2 = 6.8 min, λ = 254 cm-1. 
1H NMR (400 MHz, Chloroform-d) δ 7.62 (ddt, J = 8.4, 6.6, 1.6 Hz, 4H, Ph), 7.45 – 7.23 (m, 
9H, Ph + ArH), 7.17 (d, J = 7.5 Hz, 1H, ArH), 4.88 (s, 1H, CMeCH2), 4.85 (s, 1H, CMeCH2), 
3.20 (ddd, J = 14.3, 9.7, 3.8 Hz, 1H, CH2), 2.93 (d, J = 14.0 Hz, 1H, CH2CMe), 2.82 (ddd, J = 
15.1, 7.4, 3.7 Hz, 1H, CH2), 2.63 (d, J = 13.9 Hz, 1H, CH2CMe), 2.33 (tdd, J = 9.9, 4.4, 2.5 Hz, 
1H, CH2), 2.17 (dt, J = 13.8, 5.1 Hz, 1H, CH2), 1.98 – 1.86 (m, 1H, CH2), 1.85 – 1.78 (m, 1H, 
CH2), 1.81 (d, J = 1.3 Hz, 3H, CCH3), 0.95 (s, 9H, tBu ). 
 
13C NMR (101 MHz, Chloroform-d) δ. 205.7, 141.7, 140.5, 138.3, 135.5, 135.5, 133.4, 133.4, 
130.9, 129.3, 129.3, 129.0, 127.9, 127.6, 126.5, 115.4, 110.4, 86.1, 51.7, 46.5, 37.1, 33.7, 27.0, 
24.5, 24.3, 18.5.[13] 
IR νmax 3071 (w), 3051 (w), 2931 (m), 2894 (w), 2893 (w), 2858 (w), 2166 (w), 1693 (m), 1599 
(w), 1486 (w), 1471 (w), 1461 (w), 1448 (w), 1429 (m), 1362 (w), 1266 (w), 1250 (w), 1192 (w), 
1110 (m), 1032 (w), 1009 (w), 1000 (w), 958 (w), 942 (w), 897 (w), 876 (w), 821 (w), 773 (w), 
763 (w), 739 (s). 
HRMS (ESI) calcd for C33H37OSi+ [M+H]+ 477.2608; found 477.2603. 
[α]D25.0 +39.1 (c = 3.00, CHCl3). 
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6. Transformation of α-allyl alkynyl ketons. 
6.1 Grignard addition to compound 6a and 6b 
 
Following a reported procedure,15 allylmagnesium bromide (2.0 equiv.) was added at -10 °C to a 
solution of compound 1 in Et2O (0.05 M). The reaction is monitored by TLC 
(pentane/ethylacetate 8:2). Upon completion the reaction was quenched with water (5 mL). The 
organic layer is separated, extracted with Et2O (3 x 20 mL), washed with NaHCO3 (20 mL), brine 
(20 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude mixture was 
purified by flask chromatography (pentane/ethyl acetate 98:2) to afford the two diasteroisomers.  
 
(2S)-1-allyl-5-methoxy-2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-
inden-1-ol (7b)  
MeO
TIPSHO
 
Following the general procedure allylmagnesium bromide (160 µL, 0.252 mmol, 2.0 equiv.) was 
added at -10 °C to a solution of compound 1b (50.0 mg, 0.126 mmol) in Et2O (2.5 mL). The 
reaction is monitored by TLC (pentane/ethylacetate 8:2). After work up the crude mixture was 
purified by flask chromatography (pentane/ethyl acetate 98:2) to afford the major diasteroisomer 
(0.045 g, 0.10 mmol, 81 % yield) and the minor diastereoisomer (0.010 g, 0.023 mmol, 18 % 
yield) as colorless oils. The relative stereochemistry was determined via ROESY NMR analysis 
(see spectra section). 
Major diastereoisomer (7b) 
 
RF = 0.33 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.18 (d, J = 8.3 Hz, 1H, ArH), 6.74 (dd, J = 8.3, 2.4 Hz, 
1H, ArH), 6.69 (d, J = 2.4 Hz, 1H, ArH), 6.00 (dddd, J = 17.1, 10.2, 7.7, 6.9 Hz, 1H, CHCH2), 
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5.20 – 5.09 (m, 2H, CHCH2), 4.85 (s, 1H, CMeCH2), 4.70 – 4.63 (s, 1H, CMeCH2), 3.78 (s, 3H, 
OMe), 3.17 (d, J = 15.6 Hz, 1H, CH2), 2.98 (dd, J = 13.9, 7.8 Hz, 1H, CH2CH), 2.96 (d, J = 15.6 
Hz, 1H, CH2), 2.61 (dd, 1 H, J = 14.0, 7.0 Hz, 1H, CH2CH), 2.47 (d, 1 H, J = 13.5 Hz, 1H, 
CH2CMe), 2.19 (dd, J = 13.4, 0.8 Hz, 1H, CH2CMe), 1.97 – 1.91 (m, 3H, CMeCH2), 1.04 (m, 
21H, TIPS).   
13C NMR (101 MHz, CDCl3) δ 159.9, 143.6, 141.1, 137.6, 134.0, 124.9, 119.1, 114.5, 112.1, 
110.2, 85.1, 84.9, 55.4, 51.6, 43.0, 41.8, 41.6, 24.4, 18.6, 11.3. 
IR νmax 3019 (w), 2945 (w), 2858 (w), 2154 (w), 1216 (m), 754 (s). 
HRMS (ESI) calcd for C28H42NaO2Si+ [M+Na]+ 461.2846; found 461.2846. 
[α]D25.0 -42.6 (c = 2.33, CHCl3). 
Minor diastereoisomer (7b) 
MeO
TIPSHO
 
RF = 0.55 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.22 (d, J = 8.2 Hz, 1H, ArH), 6.73 (d, J = 8.2 Hz, 1H, 
ArH), 6.71 (s, 1H, ArH), 5.93 (dddd, J = 15.4, 11.7, 8.0, 6.3 Hz, 1H, CHCH2), 5.11 (t, J = 1.1 Hz, 
1H, CHCH2), 5.08 (ddd, J = 5.5, 2.7, 1.4 Hz, 1H, CHCH2), 4.89 (dq, J = 2.8, 1.6 Hz, 1H, 
CMeCH2), 4.79 (dd, J = 2.3, 1.2 Hz, 1H, CMeCH2), 3.78 (s, 3H, OMe), 3.20 – 3.10 (m, 1H, 
CH2CH), 2.96 (d, J = 15.2 Hz, 1H, CH2CH), 2.61 – 2.40 (m, 3H, CH2CMe + CH2), 2.25 (d, J = 
13.1 Hz, 1H, CH2CMe), 1.98 – 1.91 (m, 3H, CMeCH2), 0.93 (s, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 159.7, 142.8, 141.7, 138.0, 133.6, 125.2, 118.3, 114.5, 112.1, 
111.6, 110.2, 83.6, 55. 5, 54.8, 42.2, 40.9, 39.7, 34.2, 24.2, 18.5, 11.1. 
IR νmax 3532 (w), 2942 (s), 2865 (s), 2158 (w), 1492 (m), 1464 (m), 1259 (s), 1147 (m), 1065 
(m), 995 (m), 916 (m), 885 (m), 760 (m). 
HRMS (ESI) calcd for C28H42NaO2Si+ [M+Na]+ 461.2846; found 461.2844. 
[α]D25.0 -28.8 (c = 0.67, CHCl3). 
(2R)-1-allyl-2-((tert-butyldiphenylsilyl)ethynyl)-6-methoxy-2-(2-methylallyl)-1,2,3,4-
tetrahydronaphthalen-1-ol (7k) 
 
S44 
 
Following the general procedure allylmagnesium bromide (300 µL, 0.300 mmol, 2.0 equiv.) was 
added at -10 °C to a solution of compound 1k (75.0 mg, 0.152 mmol) in Et2O (3.0  mL). The 
reaction is monitored by TLC (pentane/ethylacetate 8:2). After work up the crude mixture was 
purified by flask chromatography (pentane/diethyl ether 98:2) to afford the major diasteroisomer 
(0.055 g, 0.12 mmol, 80 % yield) and the minor diastereoisomer (0.012 g, 0.028 mmol, 18 % 
yield) as colorless oils.  
Major diastereoisomer (7k) 
 
RF = 0.76 (pentane:diethyl ether 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.53 (d, J = 8.8 Hz, 1H, ArH), 7.51 (dd, J = 8.1, 1.4 Hz, 
2H, Ph), 7.48 – 7.45 (m, 2H, Ph), 7.38 – 7.31 (m, 2H, Ph), 7.29 – 7.21 (m, 4H, Ph), 6.81 (dd, J = 
8.7, 2.7 Hz, 1H, ArH), 6.65 (d, J = 2.7 Hz, 1H, ArH), 5.71 (dddd, J = 16.2, 11.1, 8.0, 6.2 Hz, 1H, 
CHCH2), 5.03 (t, J = 1.3 Hz, 1H, CHCH2), 5.02 – 4.98 (m, 2H, CMeCH2), 4.93 (dd, J = 2.5, 1.2 
Hz, 1H, CHCH2), 3.82 (s, 3H, OMe), 3.24 (ddd, J = 15.7, 11.7, 7.3 Hz, 1H, CH2), 2.94 (d, J = 
12.9 Hz, 1H, CH2CMe), 2.87 (dd, J = 17.7, 6.5 Hz, 1H, CH2), 2.71 (dd, J = 14.0, 6.4 Hz, 1H, 
CH2CH), 2.64 (d, J = 1.5 Hz, 1H, OH), 2.52 (ddd, J = 14.0, 7.9, 1.4 Hz, 1H, CH2CH), 2.35 (d, J 
= 12.8 Hz, 1H, CH2CMe), 2.33 (m, 1H, CH2), 2.09 (ddd, J = 14.0, 11.8, 6.7 Hz, 1H, CH2), 2.04 – 
1.99 (m, 3H, CMe), 0.91 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ  158.6, 142.8, 137.0, 135.4, 134.7, 134.1, 133.3, 133.3, 129.4, 
129.3, 129.1, 127.6, 117.3, 115.3, 113.0, 112.4, 112.0, 85.6, 55.9, 46.9, 42.3, 41.8, 29.3, 26.9, 
26.8, 25.2, 18.4. Only one Ph of the silyl group is resolved. 
IR νmax 3549 (w), 3072 (w), 3052 (w), 2953 (m), 2933 (m), 2858 (m), 2160 (w), 1609 (m), 1498 
(m), 1465 (m), 1430 (s), 1327 (m), 1259 (s), 1244 (s), 1109 (s), 1037 (s), 1005 (m), 910 (s). 
HRMS (ESI) calcd for C36H42NaO2Si+ [M+Na]+ 557.2846; found 557.2858. 
[α]D23.0 -34.6 (c = 2.25, CHCl3). 
Minor product (7k) 
 
RF = 0.36 (pentane:diethylether 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.81 (dd, J = 7.7, 1.8 Hz, 4H, Ph), 7.43 – 7.34 (m, 6H, 
Ph), 7.26 (s, 1H, ArH), 6.75 (dd, J = 8.7, 2.7 Hz, 1H, ArH), 6.63 (d, J = 2.6 Hz, 1H, ArH), 5.71 
(dddd, J = 16.6, 10.1, 8.3, 6.2 Hz, 1H, CHCH2), 5.08 – 5.00 (m, 1H, CHCH2), 4.94 (dd, J = 17.1, 
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1.8 Hz, 1H, CHCH2), 4.87 (s, 1H, CMeCH2), 4.72 (s, 1H, CMeCH2), 3.80 (s, 3H, OMe), 3.15 
(dd, J = 13.8, 8.5 Hz, 1H, CH2CH), 2.95 – 2.85 (m, 2H, CH2), 2.64 (m, 1H, CH2CH ), 2.62 (dd, J 
= 14.0, 1.6 Hz, 1H, CH2CMe), 2.37 – 2.30 (m, 1H, CH2), 2.29 (s, 1H, OH), 2.28 – 2.19 (m, 1H, 
CH2), 2.13 (d, J = 13.9 Hz, 1H, CH2CMe), 1.95 (s, 3H, CMeCH2), 1.11 (s, 9H, tBu). 
13C NMR (101 MHz, CDCl3) δ 158.4, 143.7, 135.8, 135.7, 135.6, 134.0, 133.6, 131.7, 129.5, 
128.0, 127.7, 127.6, 118.6, 115.5, 114.9, 113.2, 111.3, 84.6, 76.3, 55.2, 45.4, 45.1, 40.8, 28.2, 
27.2, 27.1, 24.7, 24.7, 18.7. One aliphatic carbon is not resolved. 
IR νmax 3549 (w), 3072 (w), 3052 (w), 2953 (m), 2933 (m), 2858 (m), 2160 (w), 1609 (m), 1498 
(m), 1465 (m), 1430 (s), 1327 (m), 1259 (s), 1244 (s), 1109 (s), 1037 (s), 1005 (m), 910 (s). 
HRMS (ESI) calcd for C36H42NaO2Si+ [M+Na]+ 557.2846; found 557.2858. 
[α]D23.0 -43.5 (c = 1.08, CHCl3). 
6.2 Ring closing metathesis with Ru(II) catalyst. 
 
In a microwave vial of 0.5 mL, compound 7b or 7k (1 equiv.) was dissolved in CH2Cl2 (0.1 M) 
with catalyst 24 (0.1 equiv.). The vial was then tightly sealed and degased three times, before 
placing it in an oil bath heated at 40 °C. The reaction was monitored by TLC (8:2 
pentane:ethylacetate). Upon completion the reaction was filtered through a plug of celite and 
purified by flash chromatography to obtain the desired tricyclic compound 8b or 8k. 
(4aR,9aS)-7-methoxy-2-methyl-9a-((triisopropylsilyl)ethynyl)-4,4a,9,9a-tetrahydro-1H-
fluoren-4a-ol (8b) 
MeO
HO
TIPS  
Compound 7b (10 mg, 0.023 mmol) was dissolved in CH2Cl2 (0.23 mL) with catalyst 24 (1.9 mg, 
2.3 μmol, 0.1 equiv.). The desired tricyclic compound 8b (7.8 mg, 0.019 mmol, 83% yield) was 
obtained as dark brown oil after column chromatography (pentane/ethyl acetate 9:1). 
RF = 0.45 (pentane:ethyl acetate 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.26 – 7.17 (m, 1H, ArH), 6.84 (d, J = 2.4 Hz, 1H, ArH)), 
6.72 (ddd, J = 8.2, 2.4, 0.8 Hz, 1H, ArH)), 5.49 (dq, J = 4.4, 1.7 Hz, 1H, CHCMe), 3.79 (s, 3H, 
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OMe), 3.14 (dt, J = 14.3, 1.1 Hz, 1H, CH2), 3.02 (ddd, J = 17.5, 4.4, 2.3 Hz, 1H, CH2CH), 2.93 
(d, J = 14.2 Hz, 1H, CH2), 2.69 – 2.53 (m, 2H, CH2CH + CH2CMe) 2.39 – 2.29 (m, 1H, 
CH2CMe), 1.80 (dd, J = 2.6, 1.4 Hz, 3H, CMe), 0.89 – 0.79 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 160.2, 145.6, 137.8, 133.6, 122.9, 118.3, 115.1, 112.0, 111.4, 
80.5, 78.1, 55.5, 49.7, 42.5, 37.5, 33.5, 24.0, 18.4, 11.1. 
IR νmax 3520 (w), 2942 (s), 2894 (m), 2864 (s), 2158 (w), 1610 (m), 1491 (m), 1464 (m), 1258 
(s), 1144 (w), 1036 (w), 885 (m). 
HRMS (ESI) calcd for C26H38O2Si [M+] 410.2641; found 410.2637. 
[α]D25.0 +3.49 (c = 0.42, CHCl3). 
(4aR,10aR)-10a-((tert-butyldiphenylsilyl)ethynyl)-7-methoxy-2-methyl-1,4,4a,9,10,10a-
hexahydrophenanthren-4a-ol (8k) 
MeO
HO
TBDPS  
The major diasteroisomer of 7k (55 mg, 0.10 mmol) was dissolved in CH2Cl2 (1.0 mL) with 
catalyst 24 (9.0 mg, 10.0 μmol, 0.1 equiv.). The desired tricyclic compound 8k (42 mg, 0.083 
mmol, 81% yield) was obtained as brown oil after column chromatography (pentane/diethyl ether 
9:1). The relative stereochemistry was determined by ROESY NMR analysis (see spectra 
section), based on a NOE signal between the OH and the TBDPS group. 
RF = 0.31 (pentane:diethyl ether 9:1). 
1H NMR (400 MHz, Benzene-d6) δ 7.76 (d, J = 8.6 Hz, 1H, ArH), 7.74 – 7.69 (m, 4H, Ph), 7.20 
– 7.13 (m, 6H, Ph), 6.79 (s, 1H, ArH), 6.64 (d, J = 2.7 Hz, 1H, ArH), 5.13 (m, 1H, CHCMe), 
3.38 (s, 3H, OMe), 3.37 – 3.28 (m, 1H, CH2), 3.03 (ddt, J = 17.6, 2.9, 1.6 Hz, 1H, CH2CMe), 
2.57 (dd, J = 17.6, 6.8 Hz, 1H, CH2), 2.54 – 2.47 (m, 1H, CH2CH), 2.44 (app. d, J = 2.2 Hz, 1H, 
OH), 2.23 – 2.14 (m, 1H, CH2CH), 2.05 – 1.94 (m, , 1H, CH2), 2.00 (dd, J = 18.9, 1.6 Hz, 1H, 
CH2CMe), 1.69 (ddd, J = 13.7, 7.5, 1.4 Hz, 1H, CH2), 1.58 (dd, J = 2.7, 1.3 Hz, 3H, CHCMe), 
1.03 (s, 9H, tBu). 
13C NMR (101 MHz, C6D6) δ 158.9, 137.2, 135.8, 135.5, 133.5, 129.6, 129.4, 127.8, 127.6, 
126.6, 117.2, 114.9, 113.3, 112.3, 82.9, 72.2, 54.5, 41.7, 40.2, 39.0, 30.5, 26.8, 26.8, 23.0, 18.3. 
There are 2 peaks missing for the Ph group. 
IR νmax 3555 (w), 3050 (w), 3049 (w), 3009 (w), 3008 (w), 3007 (w), 2931 (m), 2908 (m), 2907 
(m), 2906 (m), 2858 (m), 2161 (w), 1605 (m), 1498 (m), 1463 (m), 1431 (m), 1251 (s), 1250 (s), 
1109 (s), 1036 (s), 821 (s). 
HRMS (ESI) calcd for C34H38NaO2Si+ [M+Na]+ 529.2533; found 529.2546. 
[α]D25.0 +8.71 (c = 3.47, CHCl3). 
(4aS,10aR)-10a-((tert-butyldiphenylsilyl)ethynyl)-7-methoxy-2-methyl-1,4,4a,9,10,10a-
hexahydrophenanthren-4a-ol (8k) 
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MeO
HO
TBDPS  
The minor diasteroisomer of 7k (13 mg, 0.024 mmol) was dissolved in CH2Cl2 (0.25 mL) with 
catalyst 24 (0.60 mg, 0.70 μmol, 0.1 equiv.). The desired tricyclic compound 8k (8.0 mg, 0.016 
mmol, 65% yield) was obtained as brown oil after column chromatography (pentane/diethyl ether 
7:3 and then 6:4). 
RF = 0.31 (pentane:diethyl ether 7:3). 
1H NMR (400 MHz, Benzene-d6) δ 7.81 – 7.68 (m, 4H, Ph), 7.30 (d, J = 8.7 Hz, 1H, ArH), 7.22 
– 7.11 (m, 6H, Ph), 6.79 (dd, J = 8.7, 2.7 Hz, 1H, ArH), 6.63 (d, J = 2.7 Hz, 1H, ArH), 5.42 (m, 
1H, CHCMe), 3.33 – 3.20 (m, 1H, CH2), 3.37 (s, 3H, OMe), 2.78 (ddd, J = 17.4, 4.0, 2.0 Hz, 1H, 
CH2CH), 2.51 – 2.37 (m, 2H, CH2CH + CH2), 2.22 – 2.10 (m, 1H, CH2CMe), 2.03 – 1.87 (m, 
2H, CH2CMe + CH2), 1.56 – 1.49 (m, 3H, CMe), 1.47 (dd, J = 12.9, 6.2 Hz, 1H, CH2), 1.21 (bs, 
1H, OH), 0.86 (s, 9H, tBu). 
13C NMR (101 MHz, C6D6) δ 159.1, 137.9, 135.6, 133.9, 132.7, 131.9, 129.2, 118.8, 115.4, 
113.2, 112.8, 100.0, 80.3, 70.0, 54.5, 40.3, 39.9, 36.6, 28.7, 27.4, 26.8, 23.2, 18.5. Not all the 
aromatic peaks could be resolved. 
IR νmax 3017 (w), 2936 (w), 1670 (w), 1600 (w), 1255 (w), 1218 (m), 754 (s). 
HRMS (ESI) calcd for C34H38NaO2Si+ [M+Na]+ 529.2533; found 529.2532. 
[α]D25.0 -17.99 (c = 0.67, CHCl3). 
6.4 Cycloisomerization catalyzed by transition metals 
(S)-5'-Methoxy-3-methylspiro[cyclohexa[2,5]diene-1,2'-inden]-1'(3'H)-one (9) 
 
Following a reported procedure,17 PtCl2 (3.4 mg, 0.013 mmol, 0.1 equiv.) and two drops of 
CH3CN were added to a solution of compound 1d (31 mg, 0.13 mmol) in toluene (0.65 mL). The 
reaction was stirred at room temperature till consumption of the starting material as checked by 
TLC (pentane:ethylacetate 8:2). The mixture was filtered through a plug of celite and purified on 
deactivated silica by flash chromatography to obtain compound 9 (16 mg, 0.067 mmol, 52% 
yield) as colorless oil. 
RF = 0.52 (pentane:ethylacetate 8.2). 
                                                 
(17) J. Sun, P. Conley, L. Zhang, S.A. Kozmin, J. Am. Chem. Soc. 2006, 128, 9705-9710. 
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1H NMR (400 MHz, Benzene-d6) δ 8.32 (d, J = 9.1 Hz, 1H, ArH), 7.30 (dd, J = 9.1, 2.5 Hz, 1H, 
ArH), 7.14 (s, 1H, ArH), 7.08 (d, J = 2.5 Hz, 1H, ArH), 3.52 (s, 3H, OMe), 3.14 – 2.99 (m, 2H, 
CH2CMe), 1.61 (dd, J = 7.7, 3.3 Hz, 1H, CH2CH), 1.28 (s, 3H, CH2CMe), 0.84 (dd, J = 7.7, 4.2 
Hz, 1H, CH2CH), 0.33 (t, J = 3.8 Hz, 1H, CH2CH). 
13C NMR (101 MHz, C6D6) δ 157.6, 146.5, 143.7, 135.7, 125.6, 122.9, 119.1, 116.7, 115.2, 
106.0, 54.4, 41.4, 26.1, 24.0, 23.8, 21.4. 
IR νmax3409 (w), 2925 (w), 2864 (w), 1659 (m), 1593 (s), 1421 (w), 1290 (m), 1256 (s), 1223 (s), 
760 (s). 
HRMS (APPI negative) calcd for C16H15O2 [M+H-1] 239.1072; found 239.1052. 
[α]D25.0 -26.3 (c = 0.92, CHCl3). 
Au-Catalyzed Cyclisomerizations 
From 1d 
 
Following a slightly modified procedure,18 compound 1d (50 mg, 0.21 mmol) in CH2Cl2 (0.50 
mL) was added at 40 °C to a pre-stirred solution of PPh3AuCl (10 mg, 0.021 mmol, 0.1 equiv.) 
and AgClO4 (4.1 mg, 0.020 mmol, 0.095 equiv.) in CH2Cl2 (1.50 mL). After purification by 
column chromatography (pentane:ethylacetate 8.2) diene 12a (0.029 g, 0.12 mmol, 58% yield) as 
a yellowish oil and diene 11a (0.015 g, 0.062 mmol, 30% yield) as a yellow oil. 
 
(S)-5'-methoxy-5-methylspiro[cyclohexa[2,4]diene-1,2'-inden]-1'(3'H)-one (11a) 
 
RF = 0.5 (pentane:ethylacetate 8.2). 
1H NMR (400 MHz, Chloroform-d) δ 7.72 (d, J = 8.5 Hz, 1H, ArH), 6.91 (dd, J = 8.5, 2.2 Hz, 
1H, ArH), 6.83 (d, J = 2.1 Hz, 1H, ArH), 6.03 (dd, J = 9.4, 5.4 Hz, 1H, CHCHCH), 5.79 – 5.70 
(m, 1H, CHCH), 5.43 (d, J = 9.4 Hz, 1H, CHCHCH), 3.88 (s, 3H, OMe), 3.16 (d, J = 17.3 Hz, 
1H, CH2), 2.97 (d, J = 17.3 Hz, 1H, CH2), 2.80 (dd, J = 17.2, 2.7 Hz, 1H, CH2CMe), 1.95 (d, J = 
17.2 Hz, 1H, CH2CMe), 1.81 (s, 3H, CH2CMe). 
                                                 
(18) M.R. Luzung, J.P. Markham, F.D. Toste, J. Am. Chem. Soc. 2004, 126, 10858. 
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13C NMR (101 MHz, CDCl3) δ 208.4, 165.7, 155.0, 134.1, 128.7, 126.3, 125.5, 125.2, 118.3, 
115.5, 109.9, 55.7, 51.6, 42.0, 38.4, 23.6. 
IR νmax3019 (w), 1699 (w), 1598 (m), 1265 (w), 1218 (w), 758 (s). 
HRMS (ESI) calcd for C16H17O2+ [M+H]+ 241.1223; found 241.1228. 
[α]D25.0 +13.9 (c = 0.29, CHCl3). 
(S)-5'-methoxy-3-methylspiro[cyclohexa[2,5]diene-1,2'-inden]-1'(3'H)-one (12a) 
 
RF = 0.3 (pentane:ethylacetate 8.2). 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.5 Hz, 1H, ArH), 6.91 (dd, J = 8.4, 2.2 Hz, 
1H, ArH), 6.88 – 6.85 (m, 1H, ArH), 6.00 (dt, J = 9.9, 3.4 Hz, 1H, CHCH2), 5.49 – 5.42 (m, 1H, 
CHCHCH2), 5.16 (dt, J = 3.2, 1.7 Hz, 1H, CHCMe), 3.89 (s, 3H, OMe), 3.03 (d, J = 18.1Hz, 
CH2), 2.99 (d, J = 18.1 Hz, CH2), 2.88 – 2.76 (m, 1H, CHCH2), 2.67 – 2.56 (m, 1H, CHCH2), 
1.76 (d, J = 1.5 Hz, 3H, CHCMe). 
13C NMR (101 MHz, CDCl3) δ 205.3, 165.6, 155.6, 133.7, 128.4, 126.9, 126.6, 126.3, 121.8, 
115.7, 109.6, 55.7, 54.3, 43.3, 30.9, 23.3. 
IR νmax3019 (w), 1702 (w), 1599 (w), 1261 (w), 1225 (w), 753 (s). 
HRMS (ESI) calcd for C16H16NaO2+ [M+Na]+ 263.1042; found 263.1035. 
[α]D25.0 -2.48 (c = 2.42, CHCl3). 
(R)-2-ethynyl-6-methoxy-2-(2-methylallyl)-3,4-dihydronaphthalen-1(2H)-one (10) 
Following the general procedure and starting from substrate 1k (1.84 g, 3.43 mmol) (R)-2-
ethynyl-6-methoxy-2-(2-methylallyl)-3,4-dihydronaphthalen-1(2H)-one (10) (0.560 g, 2.20 
mmol, 64 % yield/97% ee) 19 was obtained as a yellow oil after deprotection with TBAF (6.86 
mL, 6.86 mmol, 2.00 equiv.). 
 
RF 0.42 (pentane:ethylacetate 8:2). 
1H NMR (400 MHz, Chloroform-d) δ 8.04 (d, J = 8.8 Hz, 1H, ArH), 6.83 (dd, J = 8.8, 2.5 Hz, 
1H, ArH), 6.68 (d, J = 2.5 Hz, 1H, ArH), 4.90 (dq, J = 2.8, 1.6 Hz, 1H, CCH2), 4.79 (dq, J = 1.9, 
                                                 
19 The ee was measured before TBAF deprotection via the method described for compound 6k. 
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1.0 Hz, 1H, CCH2), 3.85 (s, 3H, OCH3), 3.38 – 3.24 (m, 1H, CH2), 2.88 (dt, J = 17.0, 4.3 Hz, 1H, 
CH2), 2.81 (dd, J = 13.8, 1.1 Hz, 1H, CH2CMe), 2.60 (dd, J = 13.7, 1.0 Hz, 1H, CH2CMe), 2.25 
(dd, J = 13.5, 4.5 Hz, 1H, CH2), 2.22 (s, 1H, CCH), 1.99 (ddd, J = 13.5, 11.4, 4.2 Hz, 1H, CH2), 
1.84 (s, 3H, CMe). 
13C NMR (101 MHz, CDCl3) δ. 193.2, 163.8, 146.2, 141.9, 131.3, 124.3, 115.4, 113.5, 112.3, 
84.0, 72.6, 55.5, 44.9, 43.7, 32.9, 26.6, 24.2. 
IR νmax 3305 (w), 2943 (w), 2252 (w), 1679 (w), 1600 (m), 1264 (w), 908 (s), 732 (s). 
HRMS (ESI) calcd for C17H19O2+ [M+H]+ 255.1380; found 255.1382. 
Cycloisomerization of 10 
 
Following a slightly modified procedure,18 compound 10 (50 mg, 0.20 mmol) in CH2Cl2 (0.50 
mL) was added at 40 °C to a pre-stirred solution of PPh3AuCl (10 mg, 0.021 mmol, 0.1 equiv.) 
and AgPF6 (5.0 mg, 0.020 mmol, 0.095 equiv.) in CH2Cl2 (1.50 mL). After purification by 
column chromatography (pentane:ethylacetate 95:5 then 9:1) compound 11b was obtained  
(0.020 g, 0.079 mmol, 40% yield) as a colorless oil and diene 12b (0.012 g, 0.047 mmol, 24 % 
yield) as a colorless oil. 
(R)-6'-methoxy-5-methyl-3',4'-dihydro-1'H-spiro[cyclohexa[2,4]diene-1,2'-naphthalen]-1'-
one (11b) 
MeO
O
 
RF = 0.4 (pentane:ethylacetate 9:1). 
1H NMR (400 MHz, Benzene-d6) δ 8.36 (d, J = 8.7 Hz, 1H, ArH), 6.61 (dd, J = 8.7, 2.6 Hz, 1H, 
ArH), 6.46 (d, J = 2.6 Hz, 1H, ArH), 5.88 (dd, J = 9.6, 5.3 Hz, 1H, CHCHCH), 5.60 – 5.53 (m, 
2H, CHCHCH), 3.33 (dt, J = 17.8, 1.6 Hz, 1H, CH2), 3.21 (s, 3H, OMe), 2.83 – 2.73 (m, 1H, 
CH2CMe), 2.37 (dt, J = 17.3, 4.9 Hz, 1H, CH2), 2.04 (dt, J = 13.0, 5.0 Hz, 1H, CH2), 1.77 (d, J = 
17.5 Hz, 1H, CH2), 1.63 (td, J = 1.6, 0.9 Hz, 3H, CH2CMe), 1.56 (ddd, J = 13.0, 10.4, 4.9 Hz, 1H, 
CH2CMe). 
13C NMR (101 MHz, C6D6) δ 197.5, 163.2, 145.3, 134.6, 130.9, 125.7, 125.3, 124.3, 117.3, 
112.9, 112.7, 54.5, 46.4, 35.8, 32.5, 25.3, 23.2. 
IR νmax 3019 (w), 2936 (w), 1748 (w), 1600 (w), 1251 (m), 1222 (m), 938 (w), 756 (s). 
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HRMS (ESI) calcd for C17H18NaO2+ [M+Na]+ 277.1199; found 277.1204. 
[α]D25.0 +86.7 (c = 0.97, CHCl3). 
 
(S)-6'-methoxy-3-methyl-3',4'-dihydro-1'H-spiro[cyclohexa[2,5]diene-1,2'-naphthalen]-1'-
one (12b) 
MeO
O
 
RF = 0.2 (pentane:diethylether 8.2). 
NMR (400 MHz, Benzene-d6) δ 8.32 (d, J = 8.7 Hz, 1H, ArH), 6.59 (dd, J = 8.7, 2.6 Hz, 1H, 
ArH), 6.51 – 6.46 (d, J = 2.7 Hz, 1H, ArH), 5.79 (d, J = 1.4 Hz, 2H, CH2CHCH+ CHCH), 5.55 
(dq, J = 2.6, 1.5 Hz, 1H, CHCMe), 3.21 (s, 3H, OMe), 2.71 (dt, J = 17.4, 6.7 Hz, 1H, CH2), 2.60 
(dt, J = 17.4, 6.1 Hz, 1H, CH2), 2.44 (m, 1H, CH2CHCH), 2.37 (m, 1H, CH2CHCH), 1.90 – 1.85 
(m, 2H, CH2), 1.54 (s, 3H, CMe). 
13C NMR (101 MHz, C6D6) δ 195.9, 163.2, 145.1, 133.2, 130.8, 127.4, 126.0, 125.5, 121.5, 
113.0, 112.8, 54.5, 49.4, 36.6, 31.3, 25.2, 23.1. 
IR νmax 3019 (w), 2938 (w), 2863 (w), 1670 (w), 1600 (w), 1217 (m), 754 (s). 
HRMS (ESI) calcd for C17H18NaO2+ [M+Na]+ 277.1199; found 277.1201. 
[α]D25.0 -21.29 (c = 0.90, CHCl3). 
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7. Absolute stereochemistry 
7.1 Determination of the absolute configuration of 6d 
(2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-ol (30) 
 
In a open flask (S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (1d) 
(1.98 g, 8.24 mmol) is dissolved in MeOH (63 mL). The solution is cooled to 0 °C before the 
addition in one portion of NaBH4 (0.343 g, 9.06 mmol, 1.1 equiv.). The reaction is stirred till 
consumption of the starting material as shown by TLC (pentane:ethyl acetate, 7:3). Upon 
completion the reaction is filtered through a plug of silica, wash with ether and ethyl acetate (2 x 
50 mL) and the solvent is evaporated. The crude is purified by column chromatography 
(pentane:ethyl acetate, 95:5 and then pentane: diethyl ether 7:3) to afford the two separated 
diasteroisomers 25a and 25b (1.17 g, 4.84 mmol, 59 % yield, in 1:2 ratio) obtained as colorless 
oils.. 
Diasteroisomer (25a)  
RF = 0.35 (pentane:ethyl acetate) 
1H NMR (400 MHz, Chloroform-d) δ 7.32 (d, J = 8.2 Hz, 1H, ArH), 6.79 (dd, J = 8.2, 2.5 Hz, 
1H, ArH), 6.76 (d, J = 2.3 Hz, 1H, ArH), 5.12 (s, 1H, OHCH), 4.93 (t, J = 1.8 Hz, 1H, CMeCH2), 
4.88 (dt, J = 2.2, 1.0 Hz, 1H, CMeCH2), 3.80 (s, 3H, OMe), 3.15 (d, J = 15.6 Hz, 1H, CH2), 3.03 
(d, J = 15.6 Hz, 1H, CH2), 2.55 (dd, J = 14.0, 1.1 Hz, 1H, CH2CMe), 2.36 – 2.28 (m, 1H, 
CH2CMe), 2.12 (s, 1H, CCH), 1.98 – 1.90 (m, 3H, CMe), 1.59 (bs, 1H, OH). 
13C NMR (101 MHz, CDCl3) δ 160.5, 143.4, 142.8, 135.2, 125.7, 114.1, 113.0, 110.3, 89.6, 
82.5, 69.9, 55.4, 46.9, 43.0, 40.8, 24.2. 
IR νmax 3403 (w), 3296 (m), 3073 (w), 2943 (w), 2836 (w), 1610 (m), 1610 (m), 1493 (s), 1438 
(m), 1290 (m), 1257 (s), 1145 (m), 1145 (m), 1117 (s), 1117 (s), 1031 (s), 896 (m). 
HRMS (ESI) calcd for C16H18LiO2+ [M+Li]+ 249.1461; found 249.1465 
Diasteroisomer (25b) 
RF = 0.3 (pentane:ethyl acetate) 
1H NMR (400 MHz, Chloroform-d) δ 7.31 (d, J = 8.3 Hz, 1H, ArH), 6.79 (dd, J = 8.3, 2.4 Hz, 
1H, ArH), 6.74 (d, J = 2.3 Hz, 1H, ArH), 4.93 (s, 1H, CMeCH2), 4.83 (s, 1H, CMeCH2), 4.78 (s, 
1H, OHCH), 3.79 (s, 3H, OMe), 3.23 (d, J = 15.6 Hz, 1H, CH2), 2.94 (d, J = 15.6 Hz, 1H, CH2), 
2.58 (d, J = 13.7 Hz, 1H, CH2CMe), 2.51 – 2.40 (bs, 1H, OH), 2.36 (d, J = 13.7 Hz, 1H, 
CH2CMe), 2.26 (s, 1H, CCH), 1.96 – 1.88 (m, 3H, CMe). 
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13C NMR (101 MHz, CDCl3) δ 160.2, 142.5, 141.7, 135.0, 125.5, 114.6, 112.9, 110.2, 86.2, 
81.1, 73.5, 55.4, 50.9, 45.6, 42.8, 24.1. 
IR νmax 3528 (w), 3457 (m), 3419 (m), 3394 (m), 3340 (m), 3295 (s), 2922 (w), 1614 (m), 1613 
(m), 1493 (m), 1441 (w), 1291 (w), 1256 (s), 1114 (m), 1032 (m), 893 (w). 
HRMS (ESI) calcd for C16H18LiO2+ [M+Li]+ 249.1461; found 249.1464. 
(R/S)-(2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-
methoxy-2-phenylacetate (26) 
O
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Following a reported procedure,20 each diasteroisomer of (2S)-2-ethynyl-5-methoxy-2-(2-
methylallyl)-2,3-dihydro-1H-inden-1-ol (25) was placed in a 10 mL microwave vial with DMAP 
(0.2 equiv.), DCC (1.2 equiv.) and (R/S)-2-methoxy-2-phenylacetic acid (1.2 equiv.). The vial 
was sealed and flushed three times with vacuo/nitrogen. CH2Cl2 (0.03 M) was added and the 
reaction was stirred at room temperature for 3-4 h till the starting material is consumed as shown 
by TLC (pentane: ethyl acetate, 8:2). 
(R)-(1S,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-
phenylacetate (26A) 
 
A solution of (1S,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-ol (25a) 
(21 mg, 0.087 mmol), DMAP (2.1 mg, 0.017 mmol, 0.2 equiv.), DCC (21.5 mg, 0.104 mmol, 1.2 
equiv) and (R)-2-methoxy-2-phenylacetic acid (17.3 mg, 0.104 mmol, 1.2 equiv.) was stirred at 
room temperature in DCM (2.9 mL) till consumption of the starting material. (R)-(1R,2S)-2-
                                                 
20 Trost, B. M.; Schroeder, G. M. Chem. Eur. J. 2005, 11, 174. 
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ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-phenylacetate 
(26A) (11 mg, 0.028 mmol, 33 % yield) was obtained as a colorless oil after column 
chromatography (pentane:ethyl acetate, 9:1 and then 8:2). 
1H NMR (400 MHz, Chloroform-d) δ 7.40-7.31 (m, 6H, Ar H, H20-25 and H3), 6.76 (d, J = 7.2 
Hz, 1H, ArH, H2), 6.70 (s, 1H, H6) 6.12 (s, 1H, CCHOCO, H8), 4.73 (t, J = 1.7 Hz, 1H, 
CMeCH2, H13a), 4.68 (s, 1H, PhHOMe, H18), 4.56 (dd, J = 2.3, 1.3 Hz, 1H, CMeCH2, H13b), 
3.80 (s, 3H, Ar OMe, H7), 3.36 (s, 3H, MeOCHPh, H19), 3.08 (d, J = 15.5 Hz, 1H, CH2, H10a), 
3.01 (d, J = 15.5 Hz, 1H, CH2, H10b), 2.03 (d, J = 14.1 Hz, 1H, CH2CMe, H11a), 1.99 (s, 1H, 
CCH, H16), 1.88 (d, J = 14.2 Hz, 1H, CH2CMe, H11b), 1.61 (d, J = 1.4 Hz, 3H, CMe¸ H14). 
13C NMR (101 MHz, CDCl3) δ 169.8, 160.9, 144.6, 142.0, 136.2, 132.3, 128.9, 128.7, 127.5 
(2C), 127.4, 113.9, 113.0, 110.1, 87.8, 82.4 (2C), 70.2, 57.2, 55.4, 46.8, 43.9, 40.6, 23.8. 
IR νmax 3300 (w), 3299 (w), 3070 (w), 2935 (w), 2835 (w), 1747 (s), 1612 (m), 1493 (m), 1451 
(m), 1295 (m), 1257 (s), 1256 (s), 1172 (s), 1112 (s), 911 (m), 734 (s). 
HRMS (ESI) calcd for C25H26NaO4+ [M+Na]+ 413.1723; found 413.1723. 
(S)-(1S,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-
phenylacetate (26B) 
 
A solution of (1S,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-ol (25a) 
(20 mg, 0.083 mmol), DMAP (2.0 mg, 0.017 mmol, 0.2 equiv.), DCC (20 mg, 0.099 mmol, 1.2 
equiv.) and (S)-2-methoxy-2-phenylacetic acid (17 mg, 0.099 mmol, 1.2 equiv.) was stirred at 
room temperature in DCM (2.7 mL) till consumption of the starting material. (S)-(1R,2S)-2-
ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-phenylacetate 
(26B) (0.003 g, 8 µmol, 9 % yield) was obtained as a colorless oil after column chromatography 
(pentane:ethyl acetate, 9:1 and then 8:2). 
1H NMR (400 MHz, Chloroform-d) δ 7.32 (dd, J = 6.7, 3.2 Hz, 2H, Ph, H20-25), 7.29 – 7.26 
(m, 3H, Ph, H20-25), 7.04 (d, J = 8.3 Hz, 1H, ArH, H3), 6.70 (d, J = 2.4 Hz, 1H, ArH, H6), 6.63 
(dd, J = 8.4, 2.4 Hz, 1H, ArH, H2), 6.16 (s, 1H, CCHOCO, H8), 4.88 (t, J = 1.7 Hz, 1H, 
CMeCH2, H13a), 4.79 (dd, J = 2.2, 1.1 Hz, 1H, CMeCH2, H13b), 4.77 (s, 1H, PhHOMe, H18), 
3.77 (s, 3H, ArOMe, H7), 3.37 (s, 3H, MeOCHPh, H19), 3.12 (d, J = 15.5 Hz, 1H, CH2, H10a), 
3.05 (d, J = 15.4 Hz, 1H, CH2, H10b), 2.44 (d, J = 14.0 Hz, 1H, CH2CMe, H11a), 2.29 (d, J = 
13.9 Hz, 1H, CH2CMe, H11b), 2.07 (s, 1H, CCH, H16), 1.84 (s, 3H, CMe, H14). 
13C NMR (101 MHz, CDCl3) δ 170.2, 160.7, 144.0, 142.2, 135.9, 131.8, 128.6, 128.5, 128.5, 
127.0, 126.9, 114.4, 112.8, 110.0, 87.9, 82.9, 82.7, 77.2, 70.4, 57.4, 55.3, 46.5, 43.9, 41.2, 24.1. 
IR νmax 3303 (w), 3072 (w), 2932 (w), 2834 (w), 2252 (w), 1745 (m), 1494 (w), 1254 (m), 1195 
(m), 1171 (m), 1109 (s), 910 (s), 733 (s). 
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HRMS (ESI) calcd for C25H26NaO4+ [M+Na]+ 413.1723; found 413.1715. 
(R)-(1R,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-
phenylacetate (26C) 
 
A solution of (1R,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-ol (35 mg, 
0.14 mmol), DMAP (3.5 mg, 0.029 mmol, 0.2 equiv.), DCC (36 mg, 0.17 mmol, 1.2 equiv) and 
(R)-2-methoxy-2-phenylacetic acid (29 mg, 0.17 mmol, 1.2 equiv.) was stirred at room 
temperature in DCM (4.8 mL) till consumption of the starting material. (R)-(1R,2S)-2-ethynyl-5-
methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-phenylacetate (26C) (18 mg, 
0.046 mmol, 32 % yield, contaminated with about 20% of diastereoisomer 26D) was obtained as 
a colorless oil after column chromatography (pentane:ethyl acetate, 9:1 and then 8:2). 
1H NMR (400 MHz, Chloroform-d) δ 7.43 – 7.39 (m, 2H, Ph, H20-25), 7.34 – 7.27 (m, 3H, Ph, 
H20-25), 6.93 (d, J = 8.3 Hz, 1H, ArH, H3), 6.70 (d, J = 2.3 Hz, 1H, ArH, H6), 6.67 – 6.60 (m, 
1H, ArH, H2), 5.99 (s, 1H, CCHOCO, H8), 4.91 – 4.87 (m, 1H, CMeCH2, H13a), 4.82 (s, 1H, 
PhHOMe, H18), 4.68 (m, 1H, CMeCH2, H13b), 3.77 (s, 3H, ArOMe, H7), 3.44 (s, 3H, 
MeOCHPh, H19), 3.32 (d, J = 16.0 Hz, 1H, CH2, H10a), 3.02 (d, J = 15.9 Hz, 1H, CH2, H10b), 
2.37 (d, J = 13.8 Hz, 1H, CH2CMe, H11a), 2.28 (d, J = 13.7 Hz, 1H, CH2CMe, H11b), 2.12 (s, 
1H, CCH, H16), 1.90 (dd, J = 1.5, 0.8 Hz, 3H, CMe, H14). 
13C NMR (101 MHz, CDCl3) δ 170.5, 160.9, 143.9, 142.0, 136.3, 130.6, 128.5, 128.5, 128.4, 
127.8, 127.2, 126.9, 115.3, 113.2, 109.9, 82.7, 82.0, 77.2, 72.3, 57.5, 55.4, 46.2, 45.7, 44.0, 
23.9.21 
IR νmax 3292 (w), 3070 (w), 2934 (w), 2834 (w), 1748 (m), 1613 (w), 1494 (m), 1450 (m), 1334 
(w), 1260 (s), 1198 (m), 1170 (s), 1110 (s), 1029 (m), 1001 (m), 969 (m), 904 (m), 815 (w), 733 
(m). 
HRMS (ESI) calcd for C25H26NaO4+ [M+Na]+ 413.1723; found 413.1725. 
(S)-(1R,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-
phenylacetate (26D) 
 
                                                 
21 Two aromatic carbons are overlapping. 
S56 
 
A solution of (1R,2S)-2-ethynyl-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-ol (25b) 
(28 mg, 0.12 mmol), DMAP (2.8 mg, 0.023 mmol, 0.2 equiv.), DCC (29 mg, 0.14 mmol, 1.2 
equiv.) and (S-2-methoxy-2-phenylacetic acid (23 mg, 0.14 mmol, 1.2 equiv.) was stirred at room 
temperature in DCM (3.8 mL) till consumption of the starting material. (S)-(1R,2S)-2-ethynyl-5-
methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-yl 2-methoxy-2-phenylacetate 26d (32 mg, 
0.081 mmol, 70 % yield) was obtained as a colorless oil after column chromatography 
(pentane:ethyl acetate, 9:1 and then 8:2). 
1H NMR (400 MHz, Chloroform-d) δ  7.50 – 7.44 (m, 2H, Ph+ ArH, H3 and H20-25), 7.35 – 
7.28 (m, 4H, Ph, H20-25), 6.77 (dd, J = 8.3, 2.5 Hz, 1H, ArH, H2), 6.75 (d, J = 2.5 Hz, 1H, ArH, 
H6), 5.96 (s, 1H, CCHOCO, H8), 4.85 – 4.78 (m, 1H, CMeCH2, H13a), 4.76 (s, 1H, PhHOMe, 
H18), 4.58 (dd, J = 2.0, 1.0 Hz, 1H, CMeCH2, H13b), 3.81 (s, 3H, ArOMe, H7), 3.40 (s, 3H, 
MeOCHPh, H19), 3.27 (d, J = 15.9 Hz, 1H, CH2, H10a), 2.97 (d, J = 15.9 Hz, 1H, CH2, H10b), 
2.19 (d, J = 13.9 Hz, 1H, CH2CMe, H11a), 2.15 (d, J = 14.0 Hz, 1H, CH2CMe, H11b), (m, 1H, 
CH2CMe, H11b), 1.79 (dd, J = 1.6, 0.8 Hz, 3H, CMe, H14), 1.60 (s, 1H, CCH, H16). 
13C NMR (101 MHz, CDCl3) δ 170.3, 161.0, 144.2, 141.9, 136.5, 131.0, 128.5, 128.4, 127.8, 
127.3, 115.2, 113.2, 110.1, 84.9, 82.5, 81.6, 77.2, 72.1, 57.3, 55.4, 45.9, 45.4, 43.7, 23.8. 
IR νmax 3304 (w), 2937 (w), 2936 (w), 2935 (w), 2834 (w), 2833 (w), 2253 (w), 1745 (w), 1494 
(w), 1259 (w), 1193 (w), 1170 (m), 1170 (m), 1111 (m), 1110 (m), 1029 (w), 999 (w), 910 (s), 
732 (s). 
HRMS (ESI) calcd for C25H26NaO4+ [M+Na]+ 413.1723; found 413.1723. 
7.2 Assignment by NMR analysis 
1) Assignment of relative configuration at the five-membered ring by 1HNMR NOESY 
experiment. 
NMR tube preparation. 3.5 mg of each compound (A,B,C,D) were placed in 4 different NMR 
tubes which were sealed and flashed with vacuo/nitrogen (3 cycles). Dry C6D6 solvent (0.65 mL) 
was added to each tube. 
NOESY experiments were acquired in exactly the same conditions: 8 number of scans, rg 161 
and mixing time 1 s. 
Proton H8 present a significant NOE with protons H11 in both compound 26C and 26D, but no 
NOE is observed for this interaction in molecules 26A and 26B. However, a significant NOE is 
observed with between protons H8 and H13 in molecules 26A and 26B, which is completely 
absent in compounds 26C and 26D. (see spectra in chapter 8). This result allows assigning the 
syn configuration at the stereocenters on the five-membered ring for compounds 26C and 26D 
and the anti one for compounds 26A and 26B. 
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We can conclude by the results obtained from the chemical shift displacement and the NOESY 
experiments that the absolute configuration of the all-carbon quaternary stereocenter is S (as 
drawn in the scheme). 
2) Assignment of the absolute configuration by 1HNMR chemical shift displacement. 
 
The analysis of the chemical shift displacement is based on the work of Trost and co-workers, 
who showed that methyl-mandelic acid esters strongly favor a specific conformation as shown 
above.22 
Analysis of the anti-pair: 26A/26B 
                                                 
22 Trost, B. M.; Belletire, J. L.; Godleski, S.; McDougal, P. G.; Balkovec, J. M.; Baldwin, J. J.; Christy, M. E.; 
Ponticello, G. S.; Varga, S. L.; Springer, J. P. J. Org. Chem 1986, 51, 2370. 
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The chemical shift differences between 26A and 26B (measured in Hz for the difference of 
chemical shift for the signals δ26B-δ26A) is in full agreement with the drawn configuration. In 
particular, both protons on C11 are strongly shielded by the phenyl group on 26A and have a 
lower chemical shift, whereas the proton on C3 is shielded in 26B.23  
Analysis of the syn-pair: 31C/31D 
 
The chemical shift differences between 26D and 26C (measured in Hz for the difference of 
chemical shift for the signals δ26D-δ26C) is in full agreement with the drawn configuration. In 
particular, the proton on C3 is strongly shielded by the phenyl group on 26C and has a lower 
chemical shift, whereas the acetylene proton on C16 is shielded in 26D.23 Finally, the relative 
intensity of the anisotropy effect further confirm the assignment of the relative configuration by 
NOESY. 
                                                 
23 The exact value of the chemical shift difference at H3 could not be determined due to signal overlap. 
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7.2 Model for the absolute stereochemistry 
 
PdPd
O
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O
MeO
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The predictive model of Trost and co-workers can be used in the developed reaction.24 
 
 
                                                 
24 Trost, B. M.; Xu, J.; Schmidt, T. J. Am. Chem. Soc. 2009, 131, 18343. 
S60 
 
8. Spectra 
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